# Chapter 24: Cyclothymic Disorder

Here is the comprehensive academic chapter on the biological and neurological basis of Cyclothymic Disorder, citing only from the provided research papers.

# Chapter 5: The Biological and Neurological Basis of Cyclothymic Disorder

## Introduction

Cyclothymic disorder represents a chronic, fluctuating mood disturbance characterized by numerous periods of hypomanic symptoms and periods of depressive symptoms that do not meet the full criteria for a major mood episode (Alloy & Abramson, 2010; Brieger & Marneros, 1998). Defined by its subsyndromal nature, cyclothymia involves oscillations between depressive states—marked by sadness, anhedonia, and low energy—and hypomanic states, which include euphoria, high energy, talkativeness, and impulsivity (Alloy & Abramson, 2010). These mood episodes are typically intermittent and of short duration, often lasting only two to three days on average (Alloy & Abramson, 2010). Despite the subsyndromal intensity of its episodes, the disorder's chronicity, typically requiring a duration of at least two years for diagnosis in adults, leads to significant impairment in social and occupational functioning (Alloy & Abramson, 2010; Brieger & Marneros, 1998).

From a biological perspective, cyclothymic disorder is best understood as a constituent of the broader bipolar spectrum (Perugi, 2010; Tondo et al., 2005; Chen & Dhillon, 2022). This conceptualization is crucial, as it provides a framework for investigating the underlying neurobiological mechanisms by drawing upon research from more severe affective disorders, such as Bipolar I and Bipolar II disorder (Dias, 2010; Janas–Kozik et al., 2025). The clinical observation that a significant proportion of individuals with major depressive disorder are later diagnosed with a bipolar disorder underscores the importance of viewing these conditions along a continuum (Erten, 2021; Mitchell et al., 2008). Cyclothymia, with its characteristic mood instability, may represent an early or attenuated expression of the same underlying diathesis that gives rise to full-blown manic and depressive episodes (Alloy & Abramson, 2010; Faedda et al., 1995). Indeed, cyclothymic temperament is considered a key feature that helps identify individuals at risk for bipolar depression (Erten, 2021).

The biological underpinnings of cyclothymic disorder remain an area of nascent investigation, often inferred from studies of related affective and psychotic conditions. The field lacks definitive biomarkers, and diagnosis continues to rely on clinical phenomenology (Brieger & Marneros, 1998; Alloy & Abramson, 2010). However, by examining the neurobiological systems implicated in more extensively studied disorders like bipolar disorder and schizophrenia, we can formulate hypotheses about the potential mechanisms driving the affective instability of cyclothymia. This chapter will synthesize the available evidence from a constrained body of literature to construct a model of the biological and neurological basis of cyclothymic disorder. We will explore implicated neurotransmitter systems, neural circuits, genetic and molecular factors, and structural and functional brain abnormalities. Furthermore, we will consider the disorder from a developmental neurobiology perspective, acknowledging its frequent onset in adolescence and early adulthood (Alloy & Abramson, 2010; Erten, 2021). Finally, we will discuss the biological heterogeneity of the disorder and the implications of our current understanding for treatment and future research. This approach, while acknowledging the current limitations in direct evidence, aims to provide a comprehensive and integrated overview of the neurobiological landscape of cyclothymic disorder.

## Neurobiological Systems

The persistent mood cycling that defines cyclothymic disorder suggests a fundamental dysregulation in the neural systems responsible for emotional processing, arousal, and homeostasis. While direct biological investigations of cyclothymia are limited, evidence from related mood and psychotic disorders provides a valuable foundation for understanding its potential pathophysiology (Perugi, 2010; Akiskal, 1994). This section explores the key neurobiological systems, including neurotransmitters, neuroendocrine pathways, and circadian rhythms, that are likely implicated in the subsyndromal depressive and hypomanic fluctuations of cyclothymia.

### Neurotransmitter Systems and Neuropharmacology

The balance of key neurotransmitters is fundamental to mood regulation, and disruptions in these systems are central to leading hypotheses of affective illness (Willner, 1984; Falkai et al., 2013). The clinical effectiveness of psychotropic medications that target specific neurotransmitter pathways provides indirect but compelling evidence for their role in mood disorders (Ketterer & Buckholtz, 1989; Carvajal, 2004).

**The Serotonergic System:** The serotonin (5-HT) system has long been implicated in depression and anxiety (Smith & Blumenthal, 2015; Anisman et al., 2005). The efficacy of selective serotonin reuptake inhibitors (SSRIs) in treating depressive symptoms highlights its importance (Giacomo et al., 2023; Montgomery et al., 1993). In the context of cyclothymia and the broader bipolar spectrum, the serotonergic system appears to play a complex and sometimes paradoxical role. A crucial clinical observation is that antidepressant treatment, particularly with SSRIs, can elicit manic or hypomanic symptoms in vulnerable individuals (Giacomo et al., 2023; Kora & Kaplan, 2008). This "manic switch" is considered a significant indicator of an underlying bipolar diathesis and is a key feature distinguishing bipolar from unipolar depression (Erten, 2021; Adetunji et al., 2007; Pies, 2007). This phenomenon suggests that rather than a simple deficit of serotonin, mood instability may relate to a dysregulation or hypersensitivity within the serotonergic system, where pharmacological enhancement can push a predisposed individual from a depressive state into a hypomanic one (Swann, 2009; Kora & Kaplan, 2008). Furthermore, serotonin dysfunction may be linked to the impulsivity and compulsive behaviors that can manifest during both depressive and hypomanic phases (Batinić et al., 2017), as seen in comorbid obsessive-compulsive disorder (OCD) (di Giacomo et al., 2023). Some studies suggest that genetic polymorphisms in the serotonin transporter gene may contribute to this vulnerability (Mauracher et al., 2024).

**The Dopaminergic System:** The dopamine system is critical for reward processing, motivation, and motor control, and its dysfunction is a cornerstone of psychosis pathophysiology in schizophrenia (Dodd, 2007; Nadeem et al., 2004; Frith, 1987). Its relevance to cyclothymia is suggested by several lines of evidence. Hypomanic episodes are characterized by increased goal-directed activity, heightened energy, and grandiosity (Alloy & Abramson, 2010; Mir et al., 2022), symptoms that could be mediated by a hyperdopaminergic state (Swann, 2009). Conversely, depressive symptoms such as anhedonia (loss of pleasure) and avolition (lack of motivation) mirror the negative symptoms of schizophrenia and may reflect a hypodopaminergic state in certain neural circuits (Buchanan, 2006; Tiryaki et al., 2009). The fact that drugs which stimulate dopamine release, such as amphetamines and cocaine, can cause psychotic and manic symptoms provides further support for this link (Mauri, 2016; Lepping et al., 2015). Antipsychotic medications, which primarily act as dopamine D2 receptor blockers, are effective in treating manic episodes, including those with psychotic features, and are sometimes used in the management of bipolar spectrum disorders (Dodd, 2007; Janicak, 2014; Sajatovic et al., 2009). This suggests that dopamine dysregulation is a plausible mechanism contributing to the "highs" of cyclothymia, and potentially the "lows" as well.

**GABAergic and Glutamatergic Systems:** The balance between the brain's primary inhibitory neurotransmitter, gamma-aminobutyric acid (GABA), and its primary excitatory neurotransmitter, glutamate, is essential for neural stability. Perturbations in this balance have been implicated in a range of neuropsychiatric conditions, including epilepsy, anxiety, and schizophrenia (Sommer & Arango, 2017; Yarlagadda et al., 2007). Evidence from studies on catatonia and alcohol withdrawal, conditions characterized by extreme states of arousal and motor dysregulation, points to the involvement of GABAergic and glutamatergic transmission (Zutshi et al., 2007; Yarlagadda et al., 2007). The effectiveness of GABA-A modulators like lorazepam in treating catatonia, which can occur in severe mood disorders, suggests a role for GABA systems in managing extreme affective states (Yarlagadda et al., 2007; Cottencin et al., 2009). In the context of cyclothymia, it is conceivable that fluctuations in the GABA/glutamate balance contribute to the cycling between states of low energy/psychomotor retardation (depression) and high energy/agitation (hypomania) (Erten, 2021). Research on the prodromal phase of schizophrenia has highlighted potential decreases in GABA functioning, which could contribute to an individual's susceptibility to psychosis and cognitive decline (Sommer & Arango, 2017), features that can also be present in severe mood episodes (Erten, 2021; Tso et al., 2010).

### Neuroendocrine and Hormonal Systems

Hormonal systems play a critical role in modulating mood, stress, and behavior, and their dysregulation is frequently observed in affective disorders (Duval et al., 2010). These systems are particularly relevant to cyclothymia, given the disorder's associations with specific life periods and its symptomatic overlap with endocrine conditions.

**The Hypothalamic-Pituitary-Adrenal (HPA) Axis:** The HPA axis is the body's primary stress response system, culminating in the release of cortisol (Charmandari et al., 2003). Chronic stress and dysfunction of the HPA axis are strongly implicated in the etiology of mood disorders (Meyer & Hamel, 2014; Juruena, 2012). Hypercortisolemia and abnormal resistance to dexamethasone suppression are common findings in major depression, suggesting a failure of the negative feedback loop that normally constrains the stress response (Loosen, 1994; Steinberg, 1981; Miller, 1987). Studies have shown that prolonged dysfunction of the HPA axis, characterized by either hyper- or hypo-activity, plays a central role in the course of mood disorders (Juruena, 2012). For individuals with cyclothymia, whose moods are often highly reactive to psychosocial stressors (Alloy & Abramson, 2010), a dysregulated HPA axis could be a key biological vulnerability. Undesirable life events, particularly those involving personal disappointment and loss, have been shown to predict the onset of major depression in high-risk adolescents, an effect potentially mediated by cortisol and DHEA levels (Goodyer et al., 2000). This suggests that the mood lability in cyclothymia could be driven by an over-reactive or poorly regulated HPA axis in response to everyday stressors.

**Thyroid Hormones:** The relationship between thyroid function and mood is well-established. Both hypothyroidism and hyperthyroidism can present with significant psychiatric symptoms, including depression, anxiety, and psychosis (Hallengren, 1998; Aarab et al., 2016; Brewer, 1969). Hypothyroidism can manifest with depressive and cognitive symptoms that can be misdiagnosed as a primary psychiatric disorder (Yılmaz et al., 2005; Maududi et al., 2009), while hyperthyroidism can mimic manic or anxious states (Aarab et al., 2016). The clinical overlap is so significant that routine thyroid function screening is warranted in patients presenting with new-onset or atypical mood symptoms (Yılmaz et al., 2005; Sadek, 2023). Given that cyclothymia is defined by fluctuations between depressive and hypomanic-like states, subtle or overt thyroid dysregulation could be a contributing or even causal factor in some individuals (Dias, 2010). Some research has noted an association between abnormal thyroid profiles and emotional dysregulation in children, suggesting a developmental link (Viola, 2011).

**Gonadal Steroids and Reproductive Hormones:** Clinical observations have long noted that periods of intense hormonal fluctuation, such as the premenstrual period, pregnancy, the postpartum period, and the menopausal transition, represent times of increased vulnerability for mood disorders in women (Duval et al., 2010; Dias, 2010). Many women experience premenstrual symptoms, and a subset suffer from the more severe Premenstrual Dysphoric Disorder (PMDD), which is characterized by mood lability, irritability, and depression in the late luteal phase (Futterman & Rapkin, 2006; Giannandrea et al., 2024). The cyclical nature of these symptoms, tied directly to the menstrual cycle, provides a powerful model for hormonally-influenced mood instability (Stein et al., 2003; Halbreich, 1997). Studies have noted that women with bipolar disorder may experience premenstrual worsening of their mood symptoms (Dias, 2010). Similarly, the postpartum period is a time of high risk for severe mood episodes, including postpartum psychosis, which often represents the first expression of an underlying bipolar disorder (Wieck, 2021; Jones et al., 2001). These findings suggest that in a subgroup of individuals with cyclothymia, sensitivity to fluctuations in gonadal steroids like estrogen and progesterone may be a key pathophysiological mechanism driving mood cycling (Duval et al., 2010; Dias, 2010).

### Circadian Rhythms and Sleep

Disruptions in sleep and circadian rhythms are core features of mood disorders (Krystal et al., 2013; Latta & Cauter, 2003). The human sleep-wake cycle, along with many physiological processes like body temperature and hormone release, is governed by an internal pacemaker in the suprachiasmatic nuclei (SCN) of the hypothalamus (Latta & Cauter, 2003; Coca, 1994). In cyclothymic disorder, the cycling between depressive and hypomanic states is intrinsically linked to changes in sleep patterns. Depressive periods often involve hypersomnia (excessive sleep), while hypomanic periods are defined by a decreased need for sleep (Alloy & Abramson, 2010; Erten, 2021). This bidirectional relationship suggests a fundamental link between mood regulation and the biological clock (Zou et al., 2022).

Sleep deprivation itself can have a powerful, albeit transient, antidepressant effect in some individuals, but it can also trigger hypomanic or manic episodes in those with a bipolar vulnerability (Goetze & Tölle, 1981; Mauracher et al., 2024; Swann, 2009). This highlights the delicate balance of the sleep-wake system in maintaining mood stability. Chronic insomnia is a significant risk factor for the later development of depression and anxiety disorders (Gillin, 1998; Taylor et al., 2005), and is a frequent complaint in individuals with cyclothymia (Alloy & Abramson, 2010). Theories of seasonal affective disorder (SAD), a condition with clear links to the bipolar spectrum, posit that dysregulation of circadian rhythms in response to changes in environmental light is a primary pathogenic mechanism (Sher, 2003; Gill & Saligan, 2008). Given these connections, it is plausible that individuals with cyclothymia have an underlying instability in their circadian timing system, making them more susceptible to mood shifts in response to both internal and external factors that disrupt sleep, such as psychosocial stress or changes in daily routines (Macneil et al., 2009).

## Genetic and Molecular Basis

The tendency for mood disorders to aggregate in families has long been observed, providing strong evidence for a significant genetic contribution to their etiology (Cadoret & Winokur, 1972; Hatcher-Kay & King, 2003). While direct genetic studies of cyclothymic disorder are scarce in the available literature, its position within the bipolar spectrum allows for inferences to be drawn from research on bipolar disorder and other major psychiatric illnesses like schizophrenia (Perugi, 2010; Tondo et al., 2005). The biological basis of cyclothymia is likely rooted in a complex interplay of genetic vulnerability and environmental factors, a model that applies to most major psychiatric conditions (Vonk, 2016; Huda, 2019).

### Heritability and Familial Risk

Family, twin, and adoption studies consistently demonstrate the heritability of bipolar disorder (BD) (Duffy, 2007; Vonk, 2016; Marinković et al., 2001). The lifetime risk of developing BD is substantially higher in first-degree relatives of affected individuals (5-10%) compared to the general population (0.5-1.5%) (Marinković et al., 2001; Ghaemi, 2018). The concordance rate for monozygotic twins is markedly higher than for dizygotic twins, further supporting a strong genetic component (Dodd, 2007; Vonk, 2016). Given that cyclothymic disorder is considered a "soft" or subsyndromal form of BD (Dias, 2010; Chen & Dhillon, 2022), it is highly probable that it shares this genetic liability. Clinical features such as an early age of onset and the presence of cyclothymic temperament are associated with a stronger family history of BD, suggesting these may be markers of greater genetic loading (Erten, 2021; Faedda et al., 1995).

Similarly, a family history of BD or psychosis is a key diagnostic clue when evaluating a patient presenting with a depressive episode, helping to differentiate a bipolar from a unipolar course (Erten, 2021; Adetunji et al., 2007; Mitchell et al., 2008). The presence of affective disorders in the families of individuals with cyclothymia supports its classification as a subaffective disorder with a common pathophysiological substrate to major mood illness (Akiskal, 1994; Akiskal, 1982). Furthermore, the familial aggregation is not limited to mood disorders alone; studies have noted increased rates of alcoholism and personality disorders in the relatives of individuals with early-onset depression, suggesting a broader spectrum of familial vulnerability (Cadoret, 1976; vanValkenburg et al., 1987).

### Candidate Genes and Molecular Pathways

The mode of inheritance for bipolar spectrum disorders is complex and does not follow simple Mendelian patterns, indicating the involvement of multiple genes interacting with each other and with environmental factors (Marinković et al., 2001; Vonk, 2016). Research into schizophrenia, another severe mental illness with a strong genetic basis, has implicated multiple chromosomal linkages (e.g., on chromosomes 3p, 5q, 6p, 8p, 13q, 22q) and large trinucleotide repeats, suggesting a polygenic architecture (Dodd, 2007; Stringer et al., 2015). Similar large-scale genetic investigations in bipolar disorder have pointed to regions of interest on chromosomes 4p16, 12q23-q24, and 21q22, among others (Marinković et al., 2001). While no single gene has been definitively identified for cyclothymia or bipolar disorder, research has focused on candidate genes involved in neurotransmitter systems and neurodevelopment.

Genes related to the serotonin system, such as the serotonin transporter gene, are of particular interest given the role of serotonin in mood and the ability of serotonergic antidepressants to trigger hypomania (Giacomo et al., 2023; Marinković et al., 2001). Similarly, genes involved in the dopamine system, such as those for dopamine receptors (Dodd, 2007) and enzymes like catechol-O-methyltransferase (COMT), are plausible candidates due to dopamine's role in reward, motivation, and psychosis (Marinković et al., 2001; Gao et al., 2023).

Beyond neurotransmitter systems, molecular pathways related to cellular stress, inflammation, and neuroplasticity are emerging as critical areas of investigation. For instance, increased oxidative stress and insufficient scavengers like glutathione have been implicated in the neurobiology of psychosis risk (Sommer & Arango, 2017). It is plausible that genetic variations affecting these pathways could create a vulnerability to the mood instability seen in cyclothymia. The phenomenon of genetic anticipation—where a disorder appears with an earlier onset or increased severity in successive generations—has been observed in some families with BD and may be related to the expansion of trinucleotide repeat sequences, a mechanism known in several neurological disorders (Marinković et al., 2001). This suggests that dynamic mutations could play a role in the expression and severity of bipolar spectrum disorders.

### Gene-Environment Interactions

The development of cyclothymic disorder cannot be explained by genetics alone; environmental factors play a crucial role in triggering the expression of an underlying genetic vulnerability (Vonk, 2016; Huda, 2019). The diathesis-stress model, which has been applied to schizophrenia and depression, is highly relevant here (Lenzenweger, 2018; Meyer & Hamel, 2014). Stressful life events, particularly those occurring during critical developmental periods like childhood and adolescence, are potent triggers for the onset of mood disorders (Harris, 1991; Hatcher-Kay & King, 2003).

Childhood adversity, including abuse, neglect, and family dysfunction, is strongly associated with a higher risk for nearly all adult psychiatric disorders, including mood and personality disorders (Faravelli et al., 2014; Arnow, 2004; Seifert, 2014). Such early traumas can lead to long-term changes in stress response systems, such as the HPA axis, and may create an enduring biological vulnerability (Meyer & Hamel, 2014; Charmandari et al., 2003). For individuals with a genetic predisposition to mood instability, exposure to such stressors may precipitate the onset of cyclothymic symptoms (Miklowitz & Chang, 2008).

Furthermore, substance use represents a significant environmental factor that interacts with genetic risk. The use of cannabis, cocaine, and amphetamines can induce psychotic and manic symptoms and may precipitate the onset of a primary psychotic or mood disorder in vulnerable individuals (Mauri, 2016; Baldaçara et al., 2023; Roncero & Casas, 2004). The high comorbidity between bipolar spectrum disorders and substance use disorders suggests a shared underlying vulnerability, possibly involving reward pathways and impulse control systems (Erten, 2021; Batinić et al., 2017). This complex interplay between an inherited predisposition and a lifetime of environmental exposures ultimately shapes the clinical manifestation, course, and severity of cyclothymic disorder.

## Brain Structure and Function

The fluctuating mood states of cyclothymic disorder are fundamentally a product of brain activity. Although direct neuroimaging evidence specific to cyclothymia is sparse within the provided literature, a wealth of findings from studies on bipolar disorder, schizophrenia, and dementia offers a window into the potential structural and functional brain alterations underlying mood dysregulation (Dell’Osso et al., 2012). These studies point towards abnormalities in key brain regions and neural circuits involved in emotion processing, cognitive control, and reward, which are likely relevant to the pathophysiology of cyclothymia.

### Neuroimaging Findings: Structural Abnormalities

Structural neuroimaging techniques like Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) have been used to identify neuroanatomical differences in individuals with severe psychiatric disorders. While these findings are not diagnostic for any single condition, they reveal patterns of brain alterations that may correlate with symptoms and functional impairment (Groisman & Seminatore, 2003).

Studies in schizophrenia have consistently reported findings such as ventricular enlargement, particularly of the third and lateral ventricles, and reductions in the volume of cortical and subcortical gray matter (Dodd, 2007; Arnold, 1999). Specific regions implicated include the frontal and temporal lobes, hippocampus, thalamus, and basal ganglia (Dodd, 2007; Nafiaa et al., 2022). Similar, though often less pronounced, abnormalities have been reported in bipolar disorder (Dell’Osso et al., 2012; Vonk, 2016). For example, white matter abnormalities have been observed in adult twins with bipolar disorder (Vonk, 2016). Given that cyclothymia resides on the bipolar spectrum, it is plausible that more subtle structural variations in these same regions could contribute to the mood instability characteristic of the disorder (Perugi, 2010).

The frontal lobes, in particular, are critical for executive functions like planning, judgment, and impulse control—functions that are often compromised during hypomanic episodes (Alloy & Abramson, 2010). Lesions in the orbitofrontal cortex have been associated with abnormal social conduct and personality changes (Jurado Ma & Junqué, 2001), mirroring some of the disinhibition seen in hypomania. Similarly, frontotemporal dementia, a neurodegenerative condition, is characterized by profound changes in personality, social behavior, and emotional regulation, highlighting the crucial role of these cortical regions in maintaining stable mood and behavior (Waite et al., 2008; Vijay et al., 2023). Therefore, subtle developmental or acquired structural differences in fronto-limbic circuits could represent a core vulnerability for cyclothymia.

### Neuroimaging Findings: Functional Dysconnectivity

Functional neuroimaging, using techniques like Positron Emission Tomography (PET) and functional MRI (fMRI), allows for the investigation of brain activity and connectivity. In mood disorders, these studies have pointed not just to abnormalities in specific regions but to dysregulation within large-scale neural circuits (Dell’Osso et al., 2012).

A central model of mood regulation involves a network of interconnected cortical and subcortical regions, including the prefrontal cortex, anterior cingulate gyrus, hippocampus, amygdala, and thalamus (Dodd, 2007). In depression, studies have often shown hypoactivity in dorsolateral prefrontal cortex regions associated with cognitive control, alongside hyperactivity in limbic and paralimbic areas like the amygdala, which are involved in generating emotional responses (Dreyer-Oren et al., 2018). This pattern suggests a failure of top-down cortical control over subcortical emotion-generating structures.

Conversely, manic states may be associated with a different pattern of dysregulation within these same circuits (Phillips et al., 1990). The rapid mood shifts in cyclothymia could reflect an unstable equilibrium within this fronto-limbic network, with the brain cycling between states of cortical-limbic activity that correspond to depressive and hypomanic symptoms (Swann, 2009). The limbic system, including the hippocampus and amygdala, is densely populated with receptors for stress hormones and neurotransmitters, making it a key interface between genetic vulnerability, environmental stress, and the expression of mood symptoms (Charmandari et al., 2003; Meyer & Hamel, 2014). For instance, dysfunction in the amygdala has been linked to the heightened fear and anxiety responses seen in many psychiatric disorders (Emmett et al., 2019).

### Neurological Soft Signs and Motor Abnormalities

Neurological soft signs (NSS) are minor, non-localizing neurological deviations in motor and sensory function that are not part of a specific neurological syndrome but are more prevalent in individuals with psychiatric disorders, particularly schizophrenia (Arango et al., 2000; Sanders & Keshavan, 1998). These signs, which include impairments in motor coordination, sensory integration, and the sequencing of complex motor acts, are thought to reflect diffuse, non-specific cerebral dysfunction, potentially of a neurodevelopmental origin (Arango et al., 2000; Dodd, 2007).

In schizophrenia, NSS have been linked to the severity of disorganization and negative symptoms, suggesting they are markers of the underlying neuropathology rather than just medication side effects (Arango et al., 2000; Sanders & Keshavan, 1998). Studies of attentional and neuromotor functions have found that patients with schizophrenia show more oculomotor and stereognosis abnormalities compared to those with affective disorders (Walker, 1981). While less studied in mood disorders, motor abnormalities are a core feature of both depression (psychomotor retardation) and mania (psychomotor agitation) (Erten, 2021; Mir et al., 2022). It is therefore plausible that individuals with cyclothymia may exhibit subtle NSS that reflect the same neurodevelopmental vulnerabilities contributing to their mood instability. The presence of motor disharmony and other subtle signs in children who later develop schizophrenia supports the idea that these are early manifestations of the underlying disorder (Groisman & Seminatore, 2003; Remschmidt, 2008). Future research examining NSS in individuals with cyclothymia could help clarify the neurodevelopmental basis of the disorder.

## Developmental Neurobiology

Cyclothymic disorder, like many major psychiatric illnesses, is increasingly understood through a neurodevelopmental lens (Groisman & Seminatore, 2003; Remschmidt, 2008). The disorder typically has its onset during adolescence or early adulthood, a critical period of brain maturation, social development, and heightened vulnerability to stress (Alloy & Abramson, 2010; Erten, 2021; Steinberg, 1987). This developmental context is essential for understanding the biological mechanisms that contribute to the emergence and trajectory of cyclothymic symptoms.

### Onset in Adolescence and Early Adulthood

The onset of cyclothymia frequently occurs between the ages of 15 and 25, a period that coincides with the peak incidence for many other severe mental disorders, including schizophrenia and bipolar disorder (Erten, 2021; Janas–Kozik et al., 2025; Nadeem et al., 2004). This timing is not coincidental; adolescence is a period of profound neurobiological change, including synaptic pruning, myelination, and the maturation of key neural circuits, particularly in the prefrontal cortex which is vital for emotional regulation and impulse control (Sommer & Arango, 2017; Buitelaar, 2012). The emergence of cyclothymic mood swings during this developmental window suggests that the disorder may arise from aberrations in these maturational processes (Zauner, 1978).

Early onset of a mood disorder is often associated with a more severe and complex clinical course (Erten, 2021; Faedda et al., 1995; Akiskal, 1980). For instance, depression beginning in adolescence carries a higher risk of recurrence and greater comorbidity with anxiety and substance use disorders (Hatcher-Kay & King, 2003; Rohde et al., 1991). Cyclothymia, with its early onset, may represent a foundational liability that increases the risk for developing full-blown Bipolar I or II disorder later in life (Alloy & Abramson, 2010; Perugi, 2010; Brieger & Marneros, 1998). Retrospective studies of adults with bipolar disorder often reveal a history of symptoms starting in childhood or adolescence, underscoring the importance of recognizing these early manifestations (Nanagas, 2011; Duffy, 2007).

### Prodromal Symptoms and Early Manifestations

The concept of a prodromal phase—a period of non-specific or subthreshold symptoms preceding the first full-blown episode of an illness—is well-established in schizophrenia research (Sommer & Arango, 2017; Yung, 2011; Schultze‐Lutter, 2016) and is increasingly applied to bipolar disorder (Mehta & Rani, 2020; Miklowitz & Chang, 2008). The symptoms of cyclothymia, by their very nature, can be seen as a chronic prodromal state for more severe bipolar illness (Alloy & Abramson, 2010).

Early manifestations are often diagnostically ambiguous and can overlap with other common adolescent conditions (Janas–Kozik et al., 2025). Symptoms such as mood lability, irritability, sleep disturbances, anxiety, and changes in school performance are common in the prodrome of both psychosis and bipolar disorder (Skjelstad et al., 2012; Herz, 1985; Yung, 2011). In children and adolescents, irritability may be a more common presenting symptom of mood disturbance than classic sadness or euphoria (Carlson & Pataki, 2014; Reddy, 2014). This diagnostic challenge is compounded by high rates of comorbidity with disorders like Attention-Deficit/Hyperactivity Disorder (ADHD), anxiety disorders, and conduct disorders (Janas–Kozik et al., 2025; Perugi, 2010; Newcorn, 2008). For example, symptoms of ADHD such as inattention, impulsivity, and hyperactivity are also features of hypomanic states, making differential diagnosis difficult (Carlson & Pataki, 2014; Valdizán Usón & Izaguerri Gracia, 2009). Some research suggests that early-onset anxiety disorders, particularly OCD, may precede the development of bipolar disorder in adolescence, acting as a potential early marker of vulnerability (di Giacomo et al., 2023; Deep et al., 1995).

### The Role of Early Life Stress and Trauma

The developing brain is uniquely sensitive to the effects of environmental stressors (Meyer & Hamel, 2014). Exposure to trauma during childhood—including physical, emotional, or sexual abuse, neglect, or significant family dysfunction—is a potent risk factor for a wide range of adult psychopathologies, including mood disorders (Arnow, 2004; Huda, 2019; Faravelli et al., 2014). Such experiences can have long-lasting organizational effects on the neurobiology of stress response systems, particularly the HPA axis, leading to a state of heightened vulnerability (Charmandari et al., 2003; Ferrara, 2014).

For a genetically predisposed individual, early life adversity can act as a "second hit" that disrupts normal neurodevelopmental trajectories and precipitates the onset of mood symptoms (Dodd, 2007). The interaction between an inherited vulnerability and stressful life events is a central tenet of developmental psychopathology (Jenkins & Oatley, 1998; Miklowitz & Johnson, 2009). Childhood trauma has been associated with an earlier age of onset and a more severe course of bipolar disorder, often characterized by rapid cycling and psychotic features (Nanagas, 2011). It is therefore highly likely that such factors also play a critical role in the emergence of cyclothymic disorder, shaping its clinical presentation and long-term prognosis. Recognizing the impact of these developmental and environmental factors is crucial for early identification and for designing preventative interventions for at-risk youth (Miklowitz & Chang, 2008).

## Treatment Mechanisms

The biological basis of treatments for cyclothymic disorder is largely extrapolated from pharmacotherapy for bipolar disorder, reflecting the conceptualization of cyclothymia as part of the bipolar spectrum (Perugi, 2010; Tondo et al., 2005). The primary goal of biological interventions is to stabilize mood and prevent the cycling between depressive and hypomanic states (Alloy & Abramson, 2010). This involves targeting the same neurotransmitter and intracellular signaling pathways thought to be dysregulated in the disorder.

### Mood Stabilizers

The cornerstone of pharmacological management for bipolar spectrum disorders is mood-stabilizing agents (Grunze et al., 2009; Tondo et al., 2005). This class includes lithium and several anticonvulsant medications.

**Lithium:** For decades, lithium has been a first-line treatment for both acute mania and the long-term prevention of mood episodes in bipolar disorder (Tondo et al., 2005; Ghaemi, 2018). While its precise mechanism of action is still not fully understood, lithium is known to modulate multiple intracellular signaling pathways, including those involving inositol phosphates and glycogen synthase kinase-3 (GSK-3) (Tomasetti, 2014). By influencing these downstream pathways, lithium may correct imbalances in neurotransmission and enhance neuroprotective processes, thereby stabilizing neuronal activity and mood (Ghaemi, 2018). Its efficacy in preventing both manic and depressive relapses suggests it acts on the core pathophysiology of mood cycling (Tondo et al., 2005; Chávez-León, 2004). Given the chronic, fluctuating nature of cyclothymia, long-term prophylactic treatment with agents like lithium is a logical therapeutic strategy, aimed at dampening the oscillations that define the disorder (Brieger & Marneros, 1998). However, its use can be complicated by a narrow therapeutic window and potential for toxicity, which manifests with neurological signs such as tremor and ataxia (Pearce, 1987; Bigal et al., 2001).

**Anticonvulsants:** Several antiepileptic drugs have been found to have mood-stabilizing properties and are widely used in the treatment of bipolar disorder (McElroy et al., 1992; Tondo et al., 2005). Valproate, for example, is effective in treating acute mania and has a role in maintenance therapy (Chávez-León, 2004; McElroy et al., 1992). Its mechanisms are thought to involve the enhancement of GABAergic inhibition and modulation of intracellular signaling cascades, similar in some respects to lithium (Janicak, 2014). Lamotrigine has shown particular efficacy in the prevention of depressive episodes in bipolar disorder, making it a potentially valuable agent for cyclothymic individuals who present with a predominantly depressed pattern (Chávez-León, 2004; Tondo et al., 2005). The efficacy of these agents, which were originally developed to dampen neuronal hyperexcitability in epilepsy, supports the hypothesis that mood instability in bipolar spectrum disorders involves a state of neuronal overactivity or dysregulated signaling that can be pharmacologically targeted (McElroy et al., 1992).

### Antipsychotics

Atypical (second-generation) antipsychotics have become an integral part of the treatment for bipolar disorder, effective for acute mania, bipolar depression, and maintenance therapy (Janicak, 2014; Tondo et al., 2005). Agents like olanzapine, risperidone, quetiapine, and aripiprazole have complex pharmacological profiles, primarily involving dopamine D2 and serotonin 5-HT2A receptor antagonism (Montes & Rey, 2009; Dodd, 2007). Their efficacy in mania likely stems from their ability to modulate hyperdopaminergic states (Swann, 2009). Some atypicals, such as quetiapine and lurasidone, have also demonstrated efficacy in bipolar depression, possibly through actions on other serotonin receptor subtypes or norepinephrine systems (Mosolov, 2020; Tran & Ford, 2020). For individuals with cyclothymia, particularly those with marked irritability, impulsivity, or subthreshold psychotic features during hypomanic phases, low-dose atypical antipsychotics may provide a stabilizing effect by targeting these underlying neurotransmitter systems (Lieb et al., 2014; Grunze et al., 2009).

### The Role of Antidepressants

The use of antidepressants in bipolar spectrum disorders is controversial (Kora & Kaplan, 2008; Chávez-León, 2004). While they can be effective for treating depressive symptoms, antidepressant monotherapy carries a significant risk of inducing a switch into hypomania or mania, or accelerating the frequency of mood cycling (Giacomo et al., 2023; Swann, 2009; McElroy et al., 1992). This biological response is a key marker for a bipolar diathesis and highlights a fundamental neurobiological difference from unipolar depression (Erten, 2021; Adetunji et al., 2007). Therefore, in cyclothymic disorder, if antidepressants are used to treat depressive periods, they should be prescribed with caution, typically in combination with a mood-stabilizing agent to mitigate the risk of inducing hypomania (Tondo et al., 2005; Ghaemi, 2018). The phenomenon of antidepressant-induced mood elevation underscores the delicate balance of monoamine systems in susceptible individuals and reinforces the need for treatments that stabilize, rather than simply elevate, mood (Swann, 2009).

### Non-Pharmacological Biological Interventions

Beyond medication, other interventions that target biological systems may have a role. Psychoeducation and psychosocial therapies that emphasize the regulation of daily routines and sleep-wake cycles, such as Social Rhythm Therapy, are based on the understanding that stabilizing circadian rhythms can help stabilize mood (Macneil et al., 2009). Given the strong link between sleep disruption and mood episodes in bipolar spectrum disorders, interventions that promote sleep hygiene are biologically relevant (Erten, 2021; Alloy & Abramson, 2010). Similarly, light therapy, a primary treatment for seasonal affective disorder, works by modulating circadian systems and may have a role in some individuals with cyclothymia, particularly those with a seasonal pattern to their mood fluctuations (Sher, 2003; Gill & Saligan, 2008). These non-pharmacological approaches target the same underlying biological vulnerabilities as medications but through behavioral and environmental modifications.

## Future Directions

The biological and neurological understanding of cyclothymic disorder, while advancing, remains largely in its infancy. The current body of literature, as represented by the available sources, primarily allows for inference and hypothesis-generation based on more severe, related conditions rather than direct investigation of cyclothymia itself. This landscape points clearly toward several critical future directions for research that are necessary to elucidate the specific pathophysiology of this chronic and impairing condition.

First and foremost is the need for dedicated, large-scale longitudinal studies focusing specifically on individuals diagnosed with cyclothymic disorder (Brieger & Marneros, 1998). Such studies are essential to move beyond extrapolation. Prospective research tracking individuals from adolescence—the typical age of onset (Alloy & Abramson, 2010)—through adulthood would allow for the characterization of the disorder's natural history and its biological correlates over time. This would help clarify what proportion of individuals with cyclothymia progress to Bipolar I or II disorder and identify the biological markers that predict this transition (Faedda et al., 1995; Duffy, 2007).

A second major direction involves advanced neuroimaging. While structural and functional MRI studies have revealed abnormalities in fronto-limbic circuits in bipolar disorder and schizophrenia (Dell’Osso et al., 2012; Dodd, 2007), it is crucial to determine if individuals with cyclothymia exhibit similar, perhaps more subtle, alterations. Techniques such as diffusion tensor imaging (DTI) could investigate white matter integrity, and magnetic resonance spectroscopy (MRS) could measure concentrations of key neurochemicals like GABA and glutathione in vivo (Sommer & Arango, 2017). Such studies would help to establish whether cyclothymia lies on a neurobiological continuum with more severe affective disorders (Perugi, 2010; Tondo et al., 2005).

Third, the field of genetics and molecular biology holds immense promise. Genome-wide association studies (GWAS) have begun to identify common genetic variants associated with bipolar disorder and schizophrenia (Stringer et al., 2015). Applying these methods to well-phenotyped cyclothymia cohorts could uncover shared genetic liabilities and potentially identify genes that modulate the severity of mood cycling (Vonk, 2016; Marinković et al., 2001). Furthermore, research into epigenetics—how environmental factors like early life stress modify gene expression—is critical for understanding the gene-environment interactions that precipitate the onset of the disorder (Meyer & Hamel, 2014; Ferrara, 2014). This could lead to the identification of biomarkers that reflect both genetic risk and environmental impact.

Fourth, exploring the biological basis of clinical heterogeneity is paramount. Cyclothymic disorder presents differently across individuals, with variations in the predominance of depressive versus hypomanic symptoms, the degree of mood reactivity, and the presence of comorbid conditions like anxiety or substance use disorders (Alloy & Abramson, 2010; Perugi, 2010). Future research should aim to identify biological subtypes. For example, investigating neuroendocrine profiles, such as HPA axis responsivity or sensitivity to gonadal hormones, could help delineate subtypes with different underlying pathophysiologies and potentially different treatment responses (Duval et al., 2010; Dias, 2010; Goodyer et al., 2000). Similarly, linking chronobiological markers, such as variations in circadian clock genes, to clinical phenotypes could provide a basis for personalized interventions like targeted light therapy or social rhythm therapy (Zou et al., 2022; Macneil et al., 2009).

Finally, the development and testing of novel therapeutic agents must be informed by this growing neurobiological understanding. As our knowledge of the specific molecular pathways involved in mood instability expands—encompassing not just monoamines but also glutamatergic signaling, neuroinflammation, and intracellular cascades (Tomasetti, 2014; Sommer & Arango, 2017)—so too will the opportunities for targeted pharmacological interventions. Clinical trials are needed that specifically include patients with cyclothymic disorder to evaluate the efficacy and safety of both existing and novel treatments for this population, moving beyond the current practice of extrapolating from studies of Bipolar I disorder. Such trials should incorporate biological measures to assess target engagement and predict treatment response, paving the way for a more precise, evidence-based approach to managing this challenging disorder.

## Conclusion

Cyclothymic disorder, characterized by its chronic and fluctuating course of subsyndromal depressive and hypomanic symptoms, represents a significant clinical entity within the broader bipolar spectrum (Alloy & Abramson, 2010; Brieger & Marneros, 1998). Although direct biological research into cyclothymia is limited, a synthesis of evidence from related affective and psychotic disorders provides a foundational, albeit speculative, neurobiological framework. This framework posits that the affective instability of cyclothymia arises from a complex interplay of genetic predispositions and environmental influences, which manifest as dysregulation across multiple integrated biological systems.

The disorder's heritability is strongly suggested by its familial aggregation and its place on the bipolar spectrum, which has a clear genetic basis (Vonk, 2016; Marinković et al., 2001). This genetic vulnerability likely involves a polygenic architecture affecting neurotransmitter systems—including serotonin, dopamine, and GABA/glutamate—as well as intracellular signaling pathways and mechanisms of neurodevelopment (Dodd, 2007; Swann, 2009; Sommer & Arango, 2017). These vulnerabilities are often unmasked during the critical neurodevelopmental window of adolescence and early adulthood, a period that coincides with the typical age of onset for cyclothymia (Janas–Kozik et al., 2025; Erten, 2021).

Functionally, these genetic and developmental factors appear to converge on key neural circuits responsible for mood regulation, particularly the fronto-limbic network (Dell’Osso et al., 2012). The cycling between depressive and hypomanic states may reflect an unstable equilibrium within this system, which is further perturbed by dysregulation in neuroendocrine pathways, such as the HPA axis, and the circadian timing system (Juruena, 2012; Zou et al., 2022). Environmental factors, especially early life stress and substance use, act as potent modulators, interacting with this underlying biological susceptibility to trigger and perpetuate mood symptoms (Meyer & Hamel, 2014; Mauri, 2016).

The biological basis of treatment further supports this model. Mood stabilizers like lithium and anticonvulsants, along with atypical antipsychotics, likely exert their therapeutic effects by modulating these same dysregulated neural and intracellular pathways (Tondo et al., 2005; Janicak, 2014). The paradoxical risk of antidepressant-induced hypomania serves as a crucial clinical and biological marker, highlighting the unique neuropharmacology of the bipolar spectrum (Giacomo et al., 2023; Kora & Kaplan, 2008).

In conclusion, while our current understanding of the biological basis of cyclothymic disorder is built largely on inference and analogy, a coherent picture is beginning to emerge. Cyclothymia is not merely a collection of mild mood swings but likely represents a true neurodevelopmental disorder rooted in a genetic diathesis that impacts brain structure, function, and chemistry. The path forward requires dedicated research to test these hypotheses directly in cyclothymic populations, moving from a model of inference to one of direct evidence. Such efforts are essential for refining diagnostic criteria, developing novel and targeted treatments, and ultimately improving the long-term outcomes for individuals living with this challenging and often under-recognized condition.

## References

1. Aarab, C., Hammani, Z., Aalouane, R., Yassari, M., & Rammouz, I. (2016). Psychose aigüe secondaire à une dysthyroïdie: à propos de 2 cas. Pan African Medical Journal. https://doi.org/10.11604/pamj.2016.25.216.10247
2. Ademi, L. A., & Ademi, B. (2017). EVALUATION AND MANAGEMENT OF A CHILD WITH FEBRILE SEIZURE.
3. Adetunji, B., Matthews, M., Basil, B., & Oyemade, A. (2007). "Bipolar Family". The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0211e
4. Adicaram, D. R. S., Wijayamunige, E. S., & Arambepola, S. C. A. (2021). Vampires! Do they exist? A case of clinical vampirism. Sri Lanka Journal of Psychiatry. https://doi.org/10.4038/sljpsyc.v12i2.8299
5. Ajithakumari, G., & HEMAVATHY, V. (2023). Bounce of caregivers expressed emotions on schizophrenia. Cardiometry. https://doi.org/10.18137/cardiometry.2022.25.8187
6. Akiskal, H. S. (1980). Characterological Depressions. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1980.01780200055006
7. Akiskal, H. S. (1982). Factors associated with incomplete recovery in primary depressive illness.. PubMed.
8. Akiskal, H. S. (1994). Dysthymia: clinical and external validity. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1994.tb05879.x
9. Akram, A. S., Sarwar, R., Zafar, M. F., Umair, M., Ullah, I., & Nazir, A. (2023). First oral treatment zuranolone’s FDA approval and its impact on postpartum depression: a new hope – a correspondence. International Journal of Surgery Global Health. https://doi.org/10.1097/gh9.0000000000000345
10. AKTAŞ, S., & Karaaziz, M. (2022). COGNITIVE BEHAVIORAL THERAPY FOR THE TREATMENT OF DEPRESSION: A CASE REPORT. SOCIAL SCIENCE DEVELOPMENT JOURNAL. https://doi.org/10.31567/ssd.763
11. Al-Hakeem, H. A. M., Al-Othman, S. N., Al-Jamea, L. M., Radhi, G. A., Bu-Ali, S. A. R., & Alnasir, F. (2013). Knowledge and Behavior of Primary School Teachers Towards Attention Deficit Hyperactivity Disorder. Bahrain Medical Bulletin. https://doi.org/10.12816/0000753
12. Albano, A. M., & Silverman, W. K. (2024). Bipolar Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348367.003.0017
13. Albano, A. M., & Silverman, W. K. (2024). Bipolar Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348381.003.0016
14. Albano, A. M., & Silverman, W. K. (2024). Disruptive Mood Dysregulation Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348367.003.0016
15. Albano, A. M., & Silverman, W. K. (2024). Panic Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348381.003.0010
16. Albano, A. M., & Silverman, W. K. (2024). Tic Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348367.003.0022
17. Albano, A. M., & Silverman, W. K. (2024). Tic Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348381.003.0019
18. Alchieri, J. C., & Urquijo, S. (2022). Aspectos demenciais frontotemporais como desafios em processos periciais psicológicos. Revista Psicologia Jurídica Forense. https://doi.org/10.56492/issn.27647374.2022n1a1
19. Alexandre, S., Misery, L., Dutray, S., Chastaing, M., Consoli, S.-M., Audra, H., Bauer, D., Bertolus, S., Callot, V., Cardinaud, F., Corrin, E., Féton-Danou, N., Malet, R., Touboul, S., & Consoli, S. (2007). Functional Itch Disorder or Psychogenic Pruritus: Suggested Diagnosis Criteria From the French Psychodermatology Group. Acta Dermato Venereologica. https://doi.org/10.2340/00015555-0266
20. Allan, C. E., Valkanova, V., & Ebmeier, K. P. (2014). Depression in older people is underdiagnosed.. PubMed.
21. Alloy, L. B., & Abramson, L. Y. (2010). Cyclothymic Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0249
22. Alvarado, R., Shilling, S., & Jorquera, M. J. (2015). Uso de la Intervención Critical Time Intervention en personas con primer episodio de psicosis. Revista de la Facultad de Ciencias Médicas de Córdoba. https://doi.org/10.31053/1853.0605.v72.n4.13845
23. Alves, G. S., Silva, R. K. P., Leal, M. B. F., Ferro, B. D. M., & Trovão, L. D. O. (2024). First Episode Psychosis and Cognition. Advances in medical technologies and clinical practice book series. https://doi.org/10.4018/979-8-3693-0851-6.ch006
24. Amihăesei, I. C. (2014). Bipolar disorder, not so rare diagnosis: subtypes of different degrees of severity, diagnosis, therapy.. PubMed.
25. Amihăesei, I. C., & Cojocaru, E. (2014). Main neuroendocrine features, diagnosis and therapeutic possibilities in the chronic fatigue syndrome, an underdiagnosed entity.. PubMed.
26. Amoah, C., Heck, D. E., & Kim, H. D. (2022). Sensing metabolomics landscape unfold molecular connectivity between mental illness and drug abuse. GSC Biological and Pharmaceutical Sciences. https://doi.org/10.30574/gscbps.2022.18.3.0102
27. Ananto, A. S., & Suryati, E. (2019). Ensefalopati Hipertensi pada Anak dengan Glomerulonefritis Akut Pasca Streptokokal.
28. Andreev, A. (2000). [Differentiated types of chronic agoraphobia].. PubMed.
29. Anisman, H., Merali, Z., Poulter, M. O., & Hayley, S. (2005). Cytokines as a Precipitant of Depressive Illness: Animal and Human Studies. Current Pharmaceutical Design. https://doi.org/10.2174/1381612053381701
30. Anyfantakis, D., Symvoulakis, E. K., Vourliotaki, I., & Kastanakis, S. (2013). Schmidt's syndrome presenting as a generalised anxiety disorder: a case report.. PubMed.
31. Arandjelovic, D., Misic, P., Serafimovic, S., & Petrovic, M. (2010). P01-366 - Psychiatric Syndromes and Disorders in Older Population. European Psychiatry. https://doi.org/10.1016/s0924-9338(10)70574-5
32. Arango, C., Kirkpatrick, B., & Buchanan, R. W. (2000). Neurological Signs and the Heterogeneity of Schizophrenia. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.157.4.560
33. Araújo, F., & Horta, A. (2016). Doença Bipolar de Início Tardio: Caso Clínico. DOAJ (DOAJ: Directory of Open Access Journals).
34. Araújo, F., Almeida, T. F. D., Rodrigues, J. D., Venâncio, Â., Horta, A., & Lapa, G. (2013). 1963 – Difficulty in the psychopharmacological approach of fronto-temporal dementia- case report. European Psychiatry. https://doi.org/10.1016/s0924-9338(13)76903-7
35. Arbuck, D. M. (2022). Neurotransmitter-based diagnosis and treatment: A hypothesis (Part 1). Current psychiatry. https://doi.org/10.12788/cp.0242
36. Arbuck, D. M. (2022). Neurotransmitter-based diagnosis and treatment: A hypothesis (Part 2). Current psychiatry. https://doi.org/10.12788/cp.0253
37. Ardakani, S. K., & Maroufi, A. (2023). Abnormal Movements Resembling Tic Disorder in a Patient with Schizophrenia: A Case Report. Iranian Journal of Psychiatry and Behavioral Sciences. https://doi.org/10.5812/ijpbs-132275
38. Arnold, S. E. (1999). Schizophrenia. Humana Press eBooks. https://doi.org/10.1007/978-1-4612-1602-5_27
39. Arnone, J. M., & Conti, R. P. (2016). Kleine-Levin Syndrome: An Overview and Relevance to Nursing Practice. Journal of Psychosocial Nursing and Mental Health Services. https://doi.org/10.3928/02793695-20160219-07
40. Arnow, B. A. (2004). Relationships between childhood maltreatment, adult health and psychiatric outcomes, and medical utilization.. PubMed.
41. Arteaga, T. L., Amo, C., González, C. S., & Sánchez, D. H. (2016). Nonconvulsive status epilepticus and psychotic symptoms: case report Stato epilettico non convulsivo e sintomi psicotici: caso clinico.
42. As, B., On, C., & NIu, R. (2014). [Bipolar depression in the clinic of schizophrenia].. PubMed.
43. Asadi, S. (2023). The Role of Bio- Psychological Factors in Sleep Anxiety and Hypomania Disorder. https://doi.org/10.31579/2835-2882/016
44. Asadi, S. (2023). The Role of Genetic Mutations on Gene MYT1 Polymorphism (rs2273455) in Bipolar &amp; Borderline Personality Disorder. Clinical Research and Clinical Trials. https://doi.org/10.31579/2693-4779/132
45. Asarnow, R. F., Satz, P., Light, R., Lewis, R. S., & Neumann, E. (1991). Behavior Problems and Adaptive Functioning in Children with Mild and Severe Closed Head Injury. Journal of Pediatric Psychology. https://doi.org/10.1093/jpepsy/16.5.543
46. Assencio-Ferreira, V. J. (2001). Manifestações neurológicas na intoxicação de lactentes pela associação dimeticona e homatropina: relato de 6 casos. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2001000200017
47. Atagün, M. İ., Balaban, Ö. D., Altınbaş, K., Yeşilyurt, S., & Tan, D. (2010). Clinic determinents of cognitive dysfunctions and cognitive endophenotypes in bipolar disorder. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. https://doi.org/10.5350/dajpn2010230407t
48. Ay, D. (2010). A Case of Transient Global Amnesia due to Marijuana Use. Journal of Academic Emergency Medicine. https://doi.org/10.4170/jaem.2010.40085
49. Ayala, L., Gómez‐Revuelta, M., Requena, C. M., Acilu, E. S. D. A. G. D., Olivares, O. P., Ruíz, M. J., Morales, N. N., Martin, M., Zufiaurre, M. L., Hernández, B., Itoiz, A. A., Peña, M., & González‐Pinto, A. (2017). Clozapine: Since the very beginning?. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.1402
50. Aydınli̇, N., Çalışkan, M., Özmen, M., & Tatlı, B. (2004). Non epileptik paroksismal olaylar: olgu sunumları ile derleme Derleme. Türk Pediatri Arşivi. https://doi.org/10.4274/tpa.v39i2.5000002421
51. Baig, F., Lawton, M., Rolinski, M., Ruffmann, C., Nithi, K., Evetts, S., Fernandes, H. J. R., Ben‐Shlomo, Y., & Shulman, J. (2015). Delineating nonmotor symptoms in early Parkinson's disease and first‐degree relatives. Movement Disorders. https://doi.org/10.1002/mds.26281
52. Baldaçara, L., Ramos, A., & Castaldelli-Maia, J. M. (2023). Managing drug-induced psychosis. International Review of Psychiatry. https://doi.org/10.1080/09540261.2023.2261544
53. Balercia, G., Boscaro, M., Lombardo, F., Carosa, E., Lenzi, A., & Jannini, E. A. (2007). Sexual Symptoms in Endocrine Diseases: Psychosomatic Perspectives. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000099840
54. Ballon, J. S., & Lieberman, J. A. (2010). Advances in the Management of Treatment- Resistant Schizophrenia. FOCUS The Journal of Lifelong Learning in Psychiatry. https://doi.org/10.1176/foc.8.4.foc475
55. Banerjee, S. (2012). ADHD in Children and Adolescents: A Good Practice Guidance. InTech eBooks. https://doi.org/10.5772/28404
56. Bansal, R., & Sheldon, S. H. (2008). Parasomnias in Childhood. CRC Press eBooks. https://doi.org/10.3109/9781420048087-26
57. Barolin, G. S. (1998). Rehabilitation hospitalism. International Journal of Rehabilitation Research. https://doi.org/10.1097/00004356-199806000-00008
58. Barrio, A. G. D. (2018). Intervención Psicoterapéutica Integrada y Transdiagnóstica en los Trastornos de la Conducta Alimentaria. Revista de Psicoterapia. https://doi.org/10.33898/rdp.v29i110.248
59. Bassil, N., Ghandour, A., & Grossberg, G. T. (2011). How Anxiety Presents Differently in Older Adults: Age-Related Changes, Medical Comorbidities Alter Presentation and Treatment. Current psychiatry.
60. Basuta, K., Schneider, A., Gane, L. W., Polussa, J., Woodruff, B. K., Pretto, D., Hagerman, R. J., & Tassone, F. (2015). High functioning male with fragile X syndrome and fragile X‐associated tremor/ataxia syndrome. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.37125
61. Batinić, B., Duišin, D., & Vukosavljevic-Gvozden, T. (2017). Neurobiological bases for impulsive and compulsive behaviour: Implications for pharmacological and psychological interventions. Engrami. https://doi.org/10.5937/engrami1701017b
62. Bausewein, C., & Schildmann, E. (2022). Symptomkontrolle am Lebensende. Therapeutische Umschau. https://doi.org/10.1024/0040-5930/a001327
63. Bayliss, E. A., Shetterly, S., Drace, M. L., Norton, J. D., Maiyani, M., Gleason, K., Sawyer, J. K., Weffald, L. A., Green, A. R., Reeve, E., Maciejewski, M. L., Sheehan, O. C., Wolff, J. L., Kraus, C. R., & Boyd, C. M. (2022). Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2022.0502
64. Beaver, B. V., & Haug, L. I. (2003). Canine Behaviors Associated With Hypothyroidism. Journal of the American Animal Hospital Association. https://doi.org/10.5326/0390431
65. Becker, M. A., Weinberger, T. E., & Ocker, L. J. (2022). Mood Disorders. CRC Press eBooks. https://doi.org/10.1201/9781003099062-21
66. Beghi, E., Carpio, A., Forsgren, L., Hesdorffer, D. C., Malmgren, K., Sander, J. W., Tomson, T., & Hauser, W. A. (2009). Recommendation for a definition of acute symptomatic seizure. Epilepsia. https://doi.org/10.1111/j.1528-1167.2009.02285.x
67. Belmaker, R. H. (2004). Bipolar Disorder. New England Journal of Medicine. https://doi.org/10.1056/nejmra035354
68. Benallel, K., Nzamba, D. N., Kaddaf, A., Gartoum, M., & Kadiri, M. (2022). Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.1194
69. Bereda, G. (2023). Seizures Are the Main Sign of Epilepsy: Stages of Seizures. Pathology and Laboratory Medicine. https://doi.org/10.11648/j.plm.20230701.11
70. Bertodo, T. D. S., Gross, M. S., & Maldaner, E. B. (2018). TRANSTORNOS BIPOLAR E DEPRESSIVO: UMA REVISÃO DOS ASPECTOS CONCEITUAIS.
71. Bidaki, R., Shirazi, E., Hosseinpoor, S., & Mirhosseini, S. M. (2016). Childhood disintegrative disorder with seasonal total mutism: A rare clinical presentation. Advanced Biomedical Research. https://doi.org/10.4103/2277-9175.178069
72. Bienvenu, O. J. (2014). Depressive Mood States Following Critical Illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199653461.003.0020
73. Bigal, M. E., Bordini, C. A., & Speciali, J. G. (2001). Daily headache as a manifestation of lithium intoxication. Neurology. https://doi.org/10.1212/wnl.57.9.1733
74. Binbay, Z., Solmaz, M., Aydın, H., Kulacaoğlu, F., Sağır, S., & Lal, B. (2012). P-1214 - Very late onset schizophrenia: a case report. European Psychiatry. https://doi.org/10.1016/s0924-9338(12)75381-6
75. Bitnun, A., & Richardson, S. E. (2015). Childhood Encephalitis in Canada in 2015. Canadian Journal of Infectious Diseases and Medical Microbiology. https://doi.org/10.1155/2015/947602
76. Blasi, M. D., Pavia, L., Cavani, P., & Tosto, C. (2012). Al di là del sintomo. Il gruppo psicodinamico nelle dipendenze. Narrare i gruppi.
77. Blesa, R. (2004). Noncognitive Symptoms and Long-Term Treatment Expectations for Alzheimer Disease. Alzheimer Disease & Associated Disorders. https://doi.org/10.1097/01.wad.0000127494.03150.f8
78. Blumenthal, J. A., & Lett, H. S. (2005). Depression and Cardiac Risk. Journal of Cardiopulmonary Rehabilitation. https://doi.org/10.1097/00008483-200503000-00005
79. Bobylova, M. Y., Mukhin, K. Y., & Kulikov, A. V. (2016). PHELAN–MCDERMID SYNDROM (del 22q13 AND r(22)): LITERATURE REVIEW AND 2 CASE REPORTS. Russian Journal of Child Neurology. https://doi.org/10.17650/2073-8803-2016-11-4-33-44
80. Bollen, E., Sanders, E. A. C. M., & Velde, E. A. V. D. (2009). Presenting signs and symptoms in multiple sclerosis. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.1986.tb03274.x
81. Bolton, E., Holohan, D. R., King, L. A., & King, D. W. (2004). Acute and Post-Traumatic Stress Disorder. Routledge eBooks. https://doi.org/10.4324/9780203336960-13
82. Bonamonte, D., Foti, C., Marco, A. D., Hansel, K., Cecchini, E., Filoni, A., Prezzo, S. D., Ambrogio, F., Angelini, G. D., & Stingeni, L. (2022). Self-inflicted pathological cutaneous disorders. Part II. Italian Journal of Dermatology and Venereology. https://doi.org/10.23736/s2784-8671.22.07376-5
83. Bond, C., Morgenstern, J., & Milne, W. K. (2022). Hot off the press: <scp>MRI</scp> sensitivity for transient global amnesia. Academic Emergency Medicine. https://doi.org/10.1111/acem.14540
84. Borie, Y. A., Tamiso, A., Gutema, K., Jisso, M., Deribe, B., Fikre, R., Defar, S., Ayalew, M., & Abera, W. (2024). Psychological distress and its associated factors among people with specific chronic conditions (diabetes and/or hypertension) in the Sidama region of southern Ethiopia: A cross-sectional study. PLoS ONE. https://doi.org/10.1371/journal.pone.0303196
85. Bosanac, B., Dominik, P., Gabrić, P., Hrstić, A., Ključarić, D. K., Kužina, I., Sović, M. S., & Vandek, M. (2017). Lexical-semantic categorisation in patients of schizophrenia. https://doi.org/10.5281/zenodo.4681378
86. Bosanac, B., Dominik, P., Gabrić, P., Hrstić, A., Ključarić, D. K., Kužina, I., Sović, M. S., & Vandek, M. (2020). Lexical-semantic categorisation in patients of schizophrenia. https://doi.org/10.17605/osf.io/5z9c4
87. Bould, H., Lewis, G., Emond, A., & Crawley, E. (2010). Depression and anxiety in children with CFS/ME: cause or effect?. Archives of Disease in Childhood. https://doi.org/10.1136/adc.2009.173161
88. Boylan, K., & Eppel, A. (2008). The severe mood dysregulation phenotype: case description of a female adolescent.. PubMed.
89. Brashear, A., Sweadner, K. J., Cook, J., Swoboda, K. J., & Ozelius, L. J. (2014). ATP1A3-Related Neurologic Disorders. University of Washington, Seattle eBooks.
90. Braun-Scharm, H. (1991). [Obsessive phenomena in schizophrenic adolescents].. PubMed.
91. Bravo, B., González, S. M. B., Portilla, N. O., Laynez, M. E. G., Gutiérrez, N. S., & Sánchez, F. G. (2024). Schizophreniform disorder. Clinical manifestations and diagnosis. Purposely a case. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1542
92. Brewer, C. (1969). Psychosis due to Acute Hypothyroidism during the Administration of Carbimazole. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.115.527.1181
93. Briceño, B., Ariza-Varón, M., Pinzón, N., Castro-Sepulveda, J.-S., & Oviedo, L. (2024). Postencephalitic syndrome with immune-mediated psychosis in an adult with meningitis due to Streptococcus pneumoniae: A case report. IDCases. https://doi.org/10.1016/j.idcr.2024.e02041
94. Brieger, P., & Marneros, A. (1998). [Dysthymia and cyclothymia--serious consequences of rarely diagnosed disorders].. PubMed.
95. Brieger, P., Hensel, J., & Marneros, A. (2005). Bipolare affektive und schizoaffektive Störungen des höheren Lebensalters. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-2004-830246
96. Bromberger, J. T., & Woods, N. F. (2009). Nonhormonal Factors Associated with Psychiatric Morbidity during the Menopausal Transition and Midlife. Key issues in mental health (Online)/Key issues in mental health (Print). https://doi.org/10.1159/000209601
97. Brown, J. (2014). Fetal Alcohol Spectrum Disorders in the Criminal Justice System: A Review.
98. Brown, R. S. (2012). Disorders of the Thyroid Gland in Infancy, Childhood and Adolescence.
99. Bruno, V., & Fox, S. H. (2014). Tremor‐Predominant Fragile X‐Associated Tremor/Ataxia Syndrome in a Female. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.12129
100. Buchanan, R. W. (2006). Persistent Negative Symptoms in Schizophrenia: An Overview. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbl057
101. Buitelaar, J. K. (2012). Adolescence as a turning point: for better and worse. European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-012-0296-3
102. Burkart, J., Jong, M. C., Ilenkyo, L., Verwer, C., Weber, S., Keller, T., & Klement, P. (2017). P172 Results of a randomised controlled trial with a homeopathic complex medicinal product in children with sleep disorders and restlessness. https://doi.org/10.1136/archdischild-2017-313273.260
103. Bénony, H., Bénony-Viodé, C., & Dumas, J. (2012). Le retard mental. Le point sur... Psychologie.
104. Bénony, H., Bénony-Viodé, C., & Dumas, J. (2012). Le trouble hyperkinétique ou déficit de l'attention/hyperactivité. Le point sur... Psychologie.
105. Bénony, H., Bénony-Viodé, C., & Dumas, J. (2012). Les troubles de l'humeur. Le point sur... Psychologie.
106. Cadoret, R. J. (1976). The genetics of affective disorder and genetic counseling. Social Biology. https://doi.org/10.1080/19485565.1976.9988217
107. Cadoret, R. J., & Winokur, G. (1972). Genetic Principles in the Classification of Affective Illnesses. International Journal of Mental Health. https://doi.org/10.1080/00207411.1972.11448572
108. Camerman, A., & Camerman, N. (1980). Stereochemical similarities in chemically different antiepileptic drugs.. PubMed.
109. Campoy, A. T., Rotger, M. Y., Gutiérrez, L. R. D. L. H., González, S. M. B., & Pastorelli, R. V. (2011). Dificultad diagnóstica de los trastornos de personalidad. A propósito de un caso.. Psicologia.com.
110. Capaldi, D. M., & Kim, H. K. (2014). Comorbidity of Depression and Conduct Disorder. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199797004.013.015
111. Carlson, G. A., & Pataki, C. (2014). Presentation of Mania/Bipolar I in Youth. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199985357.003.0002
112. Carlson, G. A., & Pataki, C. (2016). Disruptive Mood Dysregulation Disorder Among Children and Adolescents. FOCUS The Journal of Lifelong Learning in Psychiatry. https://doi.org/10.1176/appi.focus.20150039
113. Carod-Artal, F. J., Irimia, P., & Ezpeleta, D. (2012). Migraña crónica: definición, epidemiología, factores de riesgo y tratamiento. Revista de Neurología. https://doi.org/10.33588/rn.5410.2012170
114. Carvajal, C. (2004). Poor response to treatment: beyond medication. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2004.6.1/ccarvajal
115. Carvajal, C. (2004). Poor response to treatment: beyond medication.. PubMed.
116. Carvajal-Lohr, A., Flores‐Ramos, M., Montejo, S. I., & Vidal, C. G. (2016). Los trastornos de ansiedad durante la transición a la menopausia. Perinatología y Reproducción Humana. https://doi.org/10.1016/j.rprh.2016.03.003
117. Castello, M., Gutiérrez, A. A., Rodríguez, L. S., Pérez, I. S., Arévalo, A. J., & Sempere, E. P. (2025). Acute confusional state vs psychological and behavioral symptoms of dementia. About a case. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2025.1797
118. Castro, N., & Paola, L. (2018). Programa educativo para disminuir el trastorno depresivo en el post parto en madres primerizas atendidas en el servicio de gineco-obstetricia del hospital general Ambato.
119. Cerón-Apipilhuasco, A., Loría-Castellanos, J., & Gómez-Bañuelos, L. V. (2023). Intoxicaciones delictivas. Anales Médicos de la Asociación Médica del Centro Médico ABC. https://doi.org/10.24875/amh.m23000027
120. Cha, Y., Baloh, R. W., Cho, C., Magnusson, M., Song, J., Strupp, M., Wuyts, F. L., & Staab, J. P. (2020). Mal de débarquement syndrome diagnostic criteria: Consensus document of the Classification Committee of the Bárány Society. Journal of Vestibular Research. https://doi.org/10.3233/ves-200714
121. Challacombe, F., & Wroe, A. L. (2013). A hidden problem: consequences of the misdiagnosis of perinatal obsessive–compulsive disorder. British Journal of General Practice. https://doi.org/10.3399/bjgp13x667376
122. Chandel, S., Choudhary, S., & Sandhu, V. K. (2023). Recurrent catatonia in a patient with Schizophrenia and autism spectrum disorder. Industrial Psychiatry Journal. https://doi.org/10.4103/ipj.ipj_247_23
123. Chaouloff, F., Dubreucq, S., Matias, I., & Marsicano, G. (2013). Physical activity feel-good effect:The role of endocannabinoids. Routledge eBooks. https://doi.org/10.4324/9780203132678-12
124. Charante, E. P. M. V., Richard, E., & Perry, M. (2022). [Forgetfulness].. PubMed.
125. Charbonnier, V., Roy, A., Seegmüller, C., Gautier, A., & Gall, D. L. (2011). Étude d'un cas de syndrome dysexécutif à prédominance cognitive chez un enfant présentant une épilepsie frontale symptomatique. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2011.0161
126. Charmandari, E., Kino, T., Souvatzoglou, E., & Chrousos, G. P. (2003). Pediatric Stress: Hormonal Mediators and Human Development. Hormone Research in Paediatrics. https://doi.org/10.1159/000069325
127. Chen, D., & LaFrance, W. C. (2018). Epilepsy and Seizures. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy10
128. Chen, J., & Dhillon, D. (2022). Bipolar Disorder. The Meducator. https://doi.org/10.15173/m.v1i42.3271
129. Chen, J., Dhillon, D., L'hoeste, J. D., & Low, A. (2022). Bipolar Disorder. The Meducator. https://doi.org/10.35493/medu.42.6
130. Chen, Y.-S. (2012). Association between chronic insomnia and depression in elderly adults. Journal of the Chinese Medical Association. https://doi.org/10.1016/j.jcma.2012.04.001
131. Chou, C. J. (2009). Mixed Episodes with Psychotic Features. CNS Spectrums. https://doi.org/10.1017/s1092852900003886
132. Chow, C. H. T., Schmidt, L. A., & Buckley, D. N. (2020). The role of anxiety and related states in pediatric postsurgical pain. Canadian Journal of Pain. https://doi.org/10.1080/24740527.2020.1847600
133. Chrzanowski, D. T., Guthrie, E., Perkins, M., & Rynn, M. A. (2014). Child and Adolescent Psychiatry. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199326075.003.0015
134. Chung, Y. I., & Lee, B. D. (2010). Similarities and Differences between DSM-IV Brief Psychotic Disorder and ICD-10 Acute and Transient Psychotic Disorder. JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION.
135. Chávez-León, E. (2004). Tratamiento farmacológico de la fase depresiva del trastorno bipolar (depresión bipolar). Segunda parte. Salud Mental.
136. Ciaranello, A., & Ciaranello, R. D. (1995). The Neurobiology of Infantile Autism. The Neuroscientist. https://doi.org/10.1177/107385849500100608
137. Citrome, L. (2015). A primer on binge eating disorder diagnosis and management. CNS Spectrums. https://doi.org/10.1017/s1092852915000772
138. Clayton, A., Dennerstein, L., Pyke, R. E., & Sand, M. (2010). Flibanserin: A Potential Treatment for Hypoactive Sexual Desire Disorder in Premenopausal Women. Women s Health. https://doi.org/10.2217/whe.10.54
139. Coca, A. (1994). Circadian rhythm and blood pressure control: physiological and pathophysiological factors.. PubMed.
140. Coccolini, F., Improta, M., Picetti, E., Vergano, L. B., Catena, F., Angelis, N. D., Bertolucci, A., Kirkpatrick, A. W., Sartelli, M., Fugazzola, P., Tartaglia, D., & Chiarugi, M. (2020). Timing of surgical intervention for compartment syndrome in different body region: systematic review of the literature. World Journal of Emergency Surgery. https://doi.org/10.1186/s13017-020-00339-8
141. Coghill, D., Bonnar, S., Duke, S., Graham, J., & Seth, S. (2009). Obsessive compulsive disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199234998.003.0020
142. Coles, C. D. (2003). Individuals Affected by Fetal Alcohol Spectrum Disorder (FASD) and Their Families: Prevention, Intervention and Support.
143. Compton, M. T., & Broussard, B. (2010). Psychosocial Treatments for Early Psychosis. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195372496.003.0016
144. Conway, K. P., Montoya, I. D., & Compton, W. M. (2007). Lifetime Psychiatric Comorbidity of Illicit Drug Use Disorders. The Psychiatric times.
145. Corruble, E., Warot, D., & Soubrie, C. (2003). Insomnia linked to medications. SLEEP. https://doi.org/10.1007/978-1-4615-0217-3_20
146. Cottencin, O., Danel, T., Goudemand, M., Thomas, P., & Consoli, S. M. (2009). Catatonia recognition and treatment.. PubMed.
147. Couto, F. S. D., & Mendonça, A. D. (2010). Sintomas psiquiátricos e comportamentais da demência. Revista Portuguesa de Clínica Geral. https://doi.org/10.32385/rpmgf.v26i1.10713
148. Creed, F., & Guthrie, E. (1987). Psychological factors in the irritable bowel syndrome.. Gut. https://doi.org/10.1136/gut.28.10.1307
149. Cruz, A. S. (2012). P-1458 - Postpartum psychosis: a case report. European Psychiatry. https://doi.org/10.1016/s0924-9338(12)75625-0
150. Cuijpers, P. (2010). Postpartum Depression. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0697
151. Daffron, G., & Ladenika, A. (2023). The Clinical Challenges of Diagnosing Behavioral Variant Frontotemporal Dementia vs Other Psychiatric Disorders. Research Square (Research Square). https://doi.org/10.21203/rs.3.rs-3258879/v1
152. Daley, M., & Cannon, T. D. (2010). Childhood Psychosis. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0172
153. Dame, C., & Casper, P. (2003). Bipolar Disorder in Children and Adolescents. PsycEXTRA Dataset. https://doi.org/10.1037/e412142005-002
154. Danilova, S. (2009). Expert Evaluation of «Another Unhealthy Conditions». European Psychiatry. https://doi.org/10.1016/s0924-9338(09)71057-0
155. Daoud, A. S. (2010). Febrile Seizures: Review Article(Review Articles ). Jordan Medical Journal.
156. Darriba, H. B. (2023). A complex polymorphous psychosis or a cycloid psychosis with a different onset?. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.2246
157. Darwish, L., Beroncal, E. L., Sison, M. V., & Swardfager, W. (2018). Depression in people with type 2 diabetes: current perspectives. Diabetes Metabolic Syndrome and Obesity. https://doi.org/10.2147/dmso.s106797
158. Das, S. K., Ghosh, A., Banerjee, N., Khaski, S., & Mukherjee, S. (2012). A patient with recurrent attacks of drowsiness and lethargy--a diagnosis not to be missed.. PubMed.
159. Dawson, S., Jordan, Z. A., & Attard, M. (2012). Carersʼ experiences of seeking help for relatives with first-episode psychosis: a systematic review of qualitative evidence.. The JBI Database of Systematic Reviews and Implementation Reports. https://doi.org/10.11124/01938924-201210561-00009
160. Debiais, S., Bonnaud, I., Ferreira-Maldent, N., Mercier, E., & Toffol, B. D. (2009). NEUROPSYCHIATRIC DISORDERS REVEALING PRIMARY ANTIPHOSPHOLIPID SYNDROME IN AN ELDERLY PATIENT. Neurology. https://doi.org/10.1212/wnl.0b013e3181a0fd69
161. Deep, A. L., Nagy, L., Weltzin, T. E., Rao, R., & Kaye, W. H. (1995). Premorbid onset of psychopathology in long‐term recovered anorexia nervosa. International Journal of Eating Disorders. https://doi.org/10.1002/1098-108x(199504)17:3<291::aid-eat2260170310>3.0.co;2-#
162. Deliagin, M. (2014). Headache in children and adolescents. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.21518/2079-701x-2014-1-40-44
163. Delitto, A., George, S. Z., Dillen, L. V., Whitman, J. M., Sowa, G., Shekelle, P., Denninger, T. R., & Godges, J. J. (2012). Low Back Pain. Journal of Orthopaedic and Sports Physical Therapy. https://doi.org/10.2519/jospt.2012.42.4.a1
164. DeLuca, G. C., & Bartleson, J. D. (2010). When and How to Investigate the Patient with Headache. Seminars in Neurology. https://doi.org/10.1055/s-0030-1249221
165. Demb, H. B., Papola, P., Rosenberg, R. L., & Plum, E. (1998). A Typical Children Followed-Up in Adolescence. Clinical Child Psychology and Psychiatry. https://doi.org/10.1177/1359104598032011
166. Demirkaya, S. K., & Yapıcı, Z. (2014). Psychiatric Symptoms in Childhood Wilson’s Disease: Case Reports. Adnan Menderes Üniversitesi Tıp Fakültesi/Journal Of Adnan Menderes University Medical Faculty. https://doi.org/10.5152/adutfd.2014.141878
167. Demirkaya, S. K., & Yapıcı, Z. (2016). Psychiatric Symptoms in Childhood Wilson’s Disease: Case Reports. Meandros Medical And Dental Journal. https://doi.org/10.4274/meandros.1878
168. Demuynck, E. M. (2016). Sharp’s syndrome and psychiatric disorders in liaison psychiatry: An observation. L information psychiatrique.
169. Deriaz, N., Willi, J., Orihuela-Flores, M., & Carminati, G. G. (2008). PERVASIVE DEVELOPMENTAL DISORDERS, AGGRESSIVE BEHAVIOUR AND SEIZURES: A CASE REPORT.
170. Derman, E., Whitesman, S., Dreyer, M., Patel, D., Nossel, C., & Schwellnus, M. (2010). Healthy lifestyle interventions in general practice: Part 12: Lifestyle and depression. South African Family Practice. https://doi.org/10.1080/20786204.2010.10873989
171. Deses, C. D. D. L. (2018). Alteraciones del sueño en personas adultas mayores. Revista de la Facultad de Medicina (México).
172. Devi, D. K. S. (2013). Study of the Differences in the Quality of Life and Disability among Patients with Schizophrenia and Bipolar Disorders and Assessment of the Burden among their Care Givers..
173. Diarra, E., Jedynak, C. P., & Verny, M. (2008). [Tremor in the elderly].. PubMed. https://doi.org/10.1684/pnv.2008.0139
174. Dias, R. D. S. (2010). Estudo comparativo do fenótipo clínico de mulheres com transtorno afetivo bipolar em fase reprodutiva da vida com e sem piora pré-menstrual do humor. https://doi.org/10.11606/t.5.2010.tde-28052010-101220
175. Dieterich, C. A., Snyder, N. D., & Villani, C. J. (2016). A legal study of children with emotional disturbance and mental health needs and implications for practice.. The Journal of Law of Education.
176. Dilsaver, S. C., Halle, M. H., & Medico, V. J. D. (1991). Symptoms of major depression: acute effect of withdrawing antidepressants. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1991.tb05531.x
177. DiMario, F. J. (2006). Children Presenting With Complex Febrile Seizures Do Not Routinely Need Computed Tomography Scanning in the Emergency Department. PEDIATRICS. https://doi.org/10.1542/peds.2005-2012
178. DiMartini, A. (2007). Natural history of alcohol use disorders in liver transplant patients. Liver Transplantation. https://doi.org/10.1002/lt.21342
179. Dobrea, C., Dell’Osso, B., Carlotta, M., Cremaschi, L., Arici, C., Benatti, B., & Carlo, A. D. (2012). Neuroimaging Data in Bipolar Disorder: An Updated View. InTech eBooks. https://doi.org/10.5772/24566
180. Dodd, M. L. (2007). BASIC PRINCIPLES OF PSYCHIATRY. CRC Press eBooks. https://doi.org/10.1201/b14430-11
181. Domínguez, L. N., Martin, P. R., Olea, A. M., Martínez, N. B., Sanjosé, G. U., González, M. M., & Tolosa-Delgado, A. (2016). Atypical Psychotic Symptoms in Lafora´s Disease: A Case Report.
182. Donaghy, M., & Rossor, M. N. (2011). Psychologically determined disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198569381.003.0153
183. Douglas, M. E., Kim, B., Mayer, G., Crosby, B., & Towe-Goodm, N. (2012). Maternal Depression, Mothering and Child Development. InTech eBooks. https://doi.org/10.5772/38048
184. Dragut, A. M., Danalache, I., Goanta, M., & Trifu, S. (2015). The Pathology of Cognitive and Language Disorganization–Between Hysteric Dissociation and Schizophrenic Split. Procedia - Social and Behavioral Sciences. https://doi.org/10.1016/j.sbspro.2015.03.081
185. Drechsler, R., Walitza, S., & Werling, A. M. (2014). Klinische Praxis der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörungen und hyperkinetischen Störungen. PSYCH up2date. https://doi.org/10.1055/s-0034-1370208
186. Dreyer-Oren, S. E., Mitnaul, L., & Holtzheimer, P. E. (2018). Mood Disorders. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy25
187. Drillien, C. M. (1972). Abnormal Neurologic Signs in the First Year of Life in Low‐birthweight Infants: Possible Prognostic Significance. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.1972.tb02639.x
188. Du, J., & Gao, Z. (2014). Recent advance in cognitive impairment in Parkinson's disease. Chinese Journal of Neuromedicine. https://doi.org/10.3760/cma.j.issn.1671-8925.2014.08.025
189. Dudek, D., & Sobański, J. A. (2012). Mental disorders in somatic diseases: psychopathology and treatment. Polskie Archiwum Medycyny Wewnętrznej. https://doi.org/10.20452/pamw.1539
190. Duffy, A. (2007). Does Bipolar Disorder Exist in Children? A Selected Review. The Canadian Journal of Psychiatry. https://doi.org/10.1177/070674370705200702
191. Duletic, N., Mijatovic-Papic, T., Cizmovic, B., & Kusturica, S. (2015). Differential Diagnostic Consideration of the Syndrome of Psychomotor Agitation in Geriatric Population. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)31130-5
192. Duval, F., Jautz-Duval, M. M., González, F., & Rabia, H. (2010). Bases neurobiológicas de vulnerabilidad psiquiátrica a lo largo de las etapas de la vida hormonal de la mujer. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272010000500005
193. Dziegielewski, S. F. (2014). Quick References. https://doi.org/10.1002/9781394260577.bapp01
194. D’cruz, M., Andrade, C., & Rao, T. S. (2020). The Expression of Intimacy and Sexuality in Persons With Dementia. Journal of Psychosexual Health. https://doi.org/10.1177/2631831820972859
195. Ebenezer, I. S. (2015). Affective Disorders 2: Bipolar Disorder. https://doi.org/10.1002/9781118385777.ch7
196. Eberlein-König, B., Rakoski, J., Ruhdorfer, S., Huss‐Marp, J., Grimm, V., Behrendt, H., & Ring, J. (2003). Idiopathic Environmental Intolerances: Psychosomatic and Somatic Aspects. Dermatology and Psychosomatics / Dermatologie und Psychosomatik. https://doi.org/10.1159/000070534
197. Ebmeier, K. P. (2010). Managing bipolar disorder in primary care..
198. Economou, N.-T., Manconi, M., Ghika, J., Raimondi, M., & Bassetti, C. L. (2011). Development of Parkinson and Alzheimer Diseases in Two Cases of Narcolepsy-Cataplexy. European Neurology. https://doi.org/10.1159/000334733
199. Edinoff, A. N., Wu, N. W., deBoisblanc, C., Feltner, C. O., Norder, M., Tzoneva, V., Kaye, A. M., Cornett, E. M., Kaye, A. D., Viswanath, O., & Urits, I. (2020). Lumateperone for the Treatment of Schizophrenia.. PubMed.
200. Ef, G., As, P., & Ta, R. (2009). [Age-related aspects of paroxysmal mental disorders in the debut of epilepsy].. PubMed.
201. Efron, D., & Freeman, J. L. (2018). Medical cannabis for paediatric developmental–behavioural and psychiatric disorders. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.13902
202. Eizaguirre, M. Á. V., & Aróstegui, J. A. I. (2014). Alcance y limitaciones del tratamiento farmacológico del Trastorno por Déficit de Atención e Hiperactividad en niños y adolescentes y Guías de Práctica Clínica: una revisión bibliográfica. Revista de la Asociación Española de Neuropsiquiatría. https://doi.org/10.4321/s0211-57352014000100004
203. El-Hamady, M. M., El-Sayed, H., Bakry, S. E., & Youniss, M. (2020). Prevalence of Anxiety Disorders in Substance Related Disorders. Benha Journal of Applied Sciences. https://doi.org/10.21608/bjas.2020.137193
204. El-Sorogy, S. E., El-Hamady, M. M., Mohamed, A. S., & Dahroug, M. M. M. (2024). Sexual Disorders in Females with Bipolar Disorder. Benha Journal of Applied Sciences. https://doi.org/10.21608/bjas.2024.275914.1354
205. Eliot, E. (2021). Assessment and Management of Psychological and Behavioral Health in Adult patients. Journal of Multiple Sclerosis. https://doi.org/10.35248/2376-0389.21.8.266
206. Emilien, G., Durlach, C., Minaker, K. L., Winblad, B., Gauthier, S., & Maloteaux, J. (2004). Behavioral and psychological impairments. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-7842-5_9
207. Emmett, S. R., Hill, N. A., & Dajas‐Bailador, F. (2019). Psychiatry. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199694938.003.0018
208. Erensoy, H., Ceylan, M. E., & Evrensel, A. (2016). Psychiatric Symptoms in Rapid-onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation Syndrome and its Treatment. Chinese Medical Journal. https://doi.org/10.4103/0366-6999.173550
209. Erten, E. (2021). Treatment of Acute and Maintenance Phase of Bipolar Depression. Nöro Psikiyatri Arşivi. https://doi.org/10.29399/npa.27408
210. Escobedo, A. D. Á. (2012). Influencia del estrés y depresión prenatal en el desarrollo del niño. Revista Peruana de Pediatría. https://doi.org/10.61651/rped.2012v65n3p158-169
211. Evayanti, L. G. (2014). SUATU LAPORAN KASUS SKIZOFRENIA AKUT PADA ANAK USIA 12 TAHUN DENGAN RIWAYAT GANGGUAN PEMUSATAN PERHATIAN DAN HIPERAKTIVITAS. DOAJ (DOAJ: Directory of Open Access Journals).
212. Evi, E., Wiguna, T., & Malik, K. (2021). KOMORBIDITAS GANGGUAN TIDUR PADA ANAK DENGAN GANGGUAN PEMUSATAN PERHATIAN DAN HIPERAKTIVTAS. Jurnal Muara Medika dan Psikologi Klinis. https://doi.org/10.24912/jmmpk.v1i1.12086
213. Evren, C., & Dalbudak, E. (2009). Relationship of Personality Trait Impulsivity with Clinical Variables in Male Alcohol-Dependent Inpatients. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology.
214. Facchinetti, F., Tarabusi, M., & Nappi, G. (1998). Premenstrual Syndrome and Anxiety Disorders: A Psychobiological Link. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000012260
215. Fachrudin, D. (2018). Skizofrenia Simpleks (sebuah studi kasus perspektif psikologi). Tunas Medika Jurnal Kedokteran & Kesehatan.
216. Factor, S. A., Podskalny, G. D., & Molho, E. (1995). Psychogenic movement disorders: frequency, clinical profile, and characteristics.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.59.4.406
217. Fadeyev, V. V., Shinalieva, K., Poluboyarinova, I. V., & Goldsmid, A. E. (2023). Psychopathological syndromes with sleep disorders in patients with type 2 diabetes mellitus. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro202312306130
218. Faedda, L., Baldessarini, R. J., Suppes, T., Tondo, L., Becker, I., & Lipschitz, D. S. (1995). Pediatric-Onset Bipolar Disorder: A Neglected Clinical and Public Health Problem Gianni. Harvard Review of Psychiatry. https://doi.org/10.3109/10673229509017185
219. Falk, A., Joseph, R., Smith, S., & Wilk, A. (2023). Mood and Anxiety Disorders: Major Depressive Disorder.. PubMed.
220. Falkai, P., Malchow, B., & Schmitt, A. (2013). Neurobiological Background of Affective Disorders. InTech eBooks. https://doi.org/10.5772/51801
221. Faravelli, C., Castellini, G., Fioravanti, G., Sauro, C. L., Pietrini, F., Lelli, L., Rotella, F., & Ricca, V. (2014). Different Childhood Adversities Are Associated with Different Symptom Patterns in Adulthood. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000363111
222. Faravelli, C., Zucchi, T., Perone, A., Salmoria, R., & Viviani, B. (2001). Social Phobia. https://doi.org/10.1002/0470846437.ch7
223. Ferguson, E., & Cassaday, H. J. (2001). Theoretical Accounts of Gulf War Syndrome: From Environmental Toxins to Psychoneuroimmunology and Neurodegeneration. Behavioural Neurology. https://doi.org/10.1155/2002/418758
224. Fernández-Egea, E., & Jones, P. B. (2023). Schizophrenia. Cambridge University Press eBooks. https://doi.org/10.1017/9781911623137.065
225. Ferrara, P. (2014). Child abuse and neglect: psychiatric and neuro-biological consequences. The Italian Journal of Pediatrics/Italian journal of pediatrics. https://doi.org/10.1186/1824-7288-40-s1-a32
226. Ferreira, M. D. C., Varanda, S., Carneiro, G., Santos, B. H. D., & Machado, Á. (2016). Parkinson disease psychosis – A case report. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.258
227. Feuerecker, R., Dieterich, M., Eckhardt‐Henn, A., & Becker‐Bense, S. (2015). Nicht-organischer Schwindel. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-0034-1385272
228. Fischer, T., Agar, M., Hosie, A., & Teodorczuk, A. (2020). Unpacking agitation in practice: a call for greater precision. Age and Ageing. https://doi.org/10.1093/ageing/afaa110
229. Foroutan, H. R., Vadiee, I., Nabavizadeh, A., Rafiee, M., Imanieh, M. H., Asadipouya, A., & Pirastehfar, M. (2005). CIDP and Achalasia: Two manifestations of a Disease or Coincidental Association. Iranian journal of medical sciences.
230. Frangou, S. (2012). To cure sometimes, to relieve often, to comfort always.. PubMed. https://doi.org/10.3969/j.issn.1002-0829.2012.06.007
231. Franz, M. R., & Schepank, H. (1997). [Mood disorders. Prevalence and course of unspecified functional disorders from the epidemiologic and psychosomatic viewpoint].. PubMed.
232. Frean, J., Jong, G. D., & Albrecht, R. (2008). Imaginary bugs, real distress: delusional parasitosis.. PubMed.
233. Frith, C. (1987). The positive and negative symptoms of schizophrenia reflect impairments in the perception and initiation of action. Psychological Medicine. https://doi.org/10.1017/s0033291700025873
234. Frommann, I., Pukrop, R., Brinkmeyer, J., Bechdolf, A., Ruhrmann, S., Berning, J., Decker, P., Riedel, M., Möller, H., Wölwer, W., Gäebel, W., Klosterkötter, J., Maier, W., & Wagner, M. (2010). Neuropsychological Profiles in Different At-Risk States of Psychosis: Executive Control Impairment in the Early—and Additional Memory Dysfunction in the Late—Prodromal State. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbp155
235. Futterman, L. A., & Rapkin, A. J. (2006). Diagnosis of premenstrual disorders.. PubMed.
236. Ganda, K. M. (2013). Psychiatric Conditions: Assessment of Disease States and Associated Dental Management Guidelines. https://doi.org/10.1002/9781119421450.ch52
237. Gao, Q., Ma, Y., & Yuan, Z. (2023). The causes of schizophrenia in adolescents. https://doi.org/10.1117/12.2669381
238. Garay, M. A., Richards, S., Mj, M. U., & Luguercho, C. (2007). [Psychotic major depressive episode: target symptoms in males and females].. PubMed.
239. García-Medall, J., & López, E. A. (2016). Perfil psicolingüístico y trastornos de comportamiento en un adulto con síndrome de Williams. Moenia: Revista lucense de lingüistica & literatura.
240. García‐Romero, R., Segura, J. L. P., Muñoz, A. D. A., Izuzquiza, I. R. D. O., Pérez, D. R., Galindo, L. M., & Pisón, J. L. (2010). Caso clínico:: Síndrome de Dravet. Boletín de la Sociedad de Pediatría de Aragón, La Rioja y Soria.
241. Garrabé, J., & Cousin, F. (2012). Acute and transient psychotic disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0081
242. Gautam, S., Jain, A., Gautam, M., Vahia, V., & Gautam, A. (2017). Clinical Practice Guidelines for the Management of Generalised Anxiety Disorder (GAD) and Panic Disorder (PD). Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.196975
243. Gay, C. (2009). [Atypical bipolar disorders].. PubMed.
244. Gałecki, P., Florkowski, A., Zboralski, K., Pietras, T., Szemraj, J., & Talarowska, M. (2010). Psychiatryczne i Psychologiczne Powikłania Zespołu Obturacyjnego Bezdechu Sennego. Advances in respiratory medicine. https://doi.org/10.5603/arm.27684
245. Geller, E., Ritvo, E., Freeman, B. J., & Yuwiler, A. (1982). Preliminary Observations on the Effect of Fenfluramine on Blood Serotonin and Symptoms in Three Autistic Boys. New England Journal of Medicine. https://doi.org/10.1056/nejm198207153070307
246. Genazzani, A. D., Ricchieri, F., Lanzoni, C., Strucchi, C., & Jasonni, V. M. (2006). Diagnostic and Therapeutic Approach to Hypothalamic Amenorrhea. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1365.009
247. Ghaemi, S. N. (2018). Children. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199995486.003.0028
248. Ghaemi, S. N. (2018). Clinical Cases. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199995486.003.0044
249. Ghaemi, S. N. (2018). Psychopharmacology in Medical Illnesses. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199995486.003.0032
250. Ghasemian, D., D’Souza, L., & Ebrahimi, S. (2012). Effectiveness of Rational Emotive Behaviour Therapy on Shyness: Influence of Age. JOURNAL OF PSYCHOSOCIAL RESEARCH.
251. Giacobbe, P., & Flint, A. J. (2007). Pharmacological treatment of poststroke pathological laughing and crying. Journal of Psychiatry and Neuroscience. https://doi.org/10.1139/jpn.0737
252. Giacomo, E. D., Moretti, F., Colmegna, F., & Clerici, M. (2023). Obsessive–compulsive disorder as the onset of bipolar disorder in adolescence. Bipolar Disorders. https://doi.org/10.1111/bdi.13373
253. Giannandrea, S. A., Chaudron, L. H., & Grady-Weliky, T. A. (2024). Premenstrual Syndrome. CRC Press eBooks. https://doi.org/10.1201/9781003579038-11
254. Gilbert‐Barness, E., Debich-Spicer, D., & Opitz, J. M. (2001). Malformation Syndromes. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511547423.010
255. Gilchrist, R. H., & Arnold, L. E. (2008). Long-term Efficacy of ADHD Pharmacotherapy in Children. Psychiatric Annals. https://doi.org/10.3928/00485713-20080101-03
256. Gill, C. E., & Kompoliti, K. (2019). Clinical Features of Tourette Syndrome. Journal of Child Neurology. https://doi.org/10.1177/0883073819877335
257. Gill, J., & Saligan, L. N. (2008). Don't let SAD get you down this season. The Nurse Practitioner. https://doi.org/10.1097/01.npr.0000342178.55661.99
258. Gillberg, C. (2014). [Not Available].. PubMed.
259. Gillen, M., Rose, E., & Schwarze, J. (2014). Conduct Disorder. https://doi.org/10.63134/nbfb7032
260. Gillin, J. C. (1998). Are sleep disturbances risk factors for anxiety, depressive and addictive disorders?. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1998.tb05965.x
261. Ginting, D. A., Jayady, A., Habibi, M. M., Andarmoyo, S., & Irawan, A. (2020). Mental health problems in covid-19 situation. European Journal of Molecular & Clinical Medicine.
262. Globas, C., Montcel, S. T. D., Baliko, L., Boesch, S., Depondt, C., DiDonato, S., Dürr, A., Filla, A., Klockgether, T., Mariotti, C., Melegh, B., Rakowicz, M., Ribaı̈, P., Rola, R., Schmitz‐Hübsch, T., Szymanski, S., Timmann, D., Warrenburg, B. P. V. D., Bauer, P., & Schöls, L. (2008). Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6. Movement Disorders. https://doi.org/10.1002/mds.22288
263. Glover, V., Liddle, P. F., Taylor, A., Adams, D., & Sandler, M. (1994). Mild Hypomania (the Highs) can be a Feature of the First Postpartum Week. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.164.4.517
264. Godiawala, S. P., Parikh, M., & Kumar, R. (2024). Unraveling the Diagnostic Challenge: A Case Report on Disruptive Mood Dysregulation Disorder. Indian Journal of Clinical Psychiatry.. https://doi.org/10.54169/ijocp.v4i02.118
265. Goenjian, A., Steinberg, A. M., & Pynoos, R. S. (2022). Long-Term Course of PTSD and Depression Among Adults, Mediating and Moderating Factors in Recovery, and Current Trends for Treatment. Cambridge University Press eBooks. https://doi.org/10.1017/9781108877992.008
266. Gold, M. S. (1981). Diagnosis of Depression in the 1980s. JAMA. https://doi.org/10.1001/jama.1981.03310400044029
267. Gold, M. S. (1981). Diagnosis of depression in the 1980s. JAMA. https://doi.org/10.1001/jama.245.15.1562
268. Golden, C. J., & Golden, Z. L. (2004). Traumatic Brain Injury. Routledge eBooks. https://doi.org/10.4324/9780203336960-19
269. Goldenberg, D. L., & Dichter, M. A. (2022). Long‐COVID Disease or Long‐COVID Syndrome?. https://doi.org/10.1002/9781119891338.ch1
270. Goldstein, T. R. (2010). Bipolar Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0134
271. Gomathy, S. B., Saini, A., Gupta, A., Vishnu, V. Y., Singh, M. B., Bhatia, R., Srivastava, M. P., Radhakrishnan, D. M., Srivastava, A. K., & Rajan, R. (2024). A rare yet treatable case of paroxysmal kinesigenic dyskinesia. Annals of Movement Disorders. https://doi.org/10.4103/aomd.aomd_28_23
272. González, A. (2005). Fisiopatología y diagnóstico de la anorexia nerviosa y la bulimia.
273. González, S. M. B., Campoy, A. T., Carballeda, J. M., Pastorelli, R. V., & Vallejo, J. V. G. (2011). ¿Manía vs psicosis tóxica vs trastornos de conducta? A propósito de un caso.. Psiquiatria.com.
274. González-Calvo, I., Ronald, A., Havers, L., Marinca, A. A., Taylor, M. J., & Hosang, G. M. (2024). Subclinical hypomania in youth and bipolar disorder: a phenotypic continuum? A critical review. https://doi.org/10.31234/osf.io/xdej8
275. Goodyer, I., Herbert, J., Tamplin, A. K., & Altham, P. M. E. (2000). Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.177.6.499
276. Goto, F., Morimoto, N., & Taiji, H. (2013). Two Cases of Pediatric Psychogenic Gait Disturbance. Nippon Jibiinkoka Gakkai Kaiho. https://doi.org/10.3950/jibiinkoka.116.91
277. Green, A. J. E., Andrews, M. M., Bishop, M., McKenzie, J. M., McCord, Y., Pennington, C., Chohan, G., & Knight, R. (2010). Elevated phosphorylated tau pT-181 in a possible PRNP codon 129 MV vCJD case. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2009.183418
278. Greydanus, D. E., Calles, J. L., & Patel, D. R. (2008). Anxiety disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544705.007
279. Greydanus, D. E., Calles, J. L., & Patel, D. R. (2008). Autism spectrum disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544705.012
280. Grigorenko, E. L., Klin, A., & Volkmar, F. R. (2003). Annotation: Hyperlexia: disability or superability?. Journal of Child Psychology and Psychiatry. https://doi.org/10.1111/1469-7610.00193
281. Grills, A. E., Seligman, L. D., & Ollendick, T. H. (2014). Anxiety Disorders in Children and Adolescents. https://doi.org/10.1002/9781118775349.ch22
282. Groisman, A. E., & Seminatore, M. L. (2003). Children and Adolescents Who Have Schizophrenia. Pediatrics in Review. https://doi.org/10.1542/pir.24.10.356
283. Grover, S., Sarkar, S., Jhanda, S., & Chawla, Y. (2014). Psychosis in an adolescent with Wilson′s disease: A case report and review of the literature. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.146530
284. Gruber, G., Saletu‐Zyhlarz, G., Anderer, P., Metka, M., Huber, J. C., Grätzhofer, E., & Saletu, B. (2007). Insomnia During Menopause. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-115-4_18
285. Grunze, H., Forsthoff, A., & Born, C. (2009). Polypharmazie in der Behandlung bipolarer Störungen. https://doi.org/10.1007/978-3-211-79826-3_3
286. Guamanarca, R. I. S., Loraque, N. B., Rubio, A. L., García, M. M., Lupiañez, I. J., & Llaría, M. M. M. (2025). SÍNDROME DE EKBOM EN PACIENTE GERIÁTRICO. A PROPÓSITO DE UN CASO.. Revista sanitaria de investigación.. https://doi.org/10.34896/rsi.2025.31.47.002
287. Gudkova, M., Krymskaia, M. L., & Solov'ëva, A. D. (1994). [Clinical-physiological characteristics and hormone therapy of patients with typical form of climacteric syndrome].. PubMed.
288. Guerdjikova, A. I., McElroy, S. L., Barger, S. D., Barth, J., Farrelly, S., & Brohan, E. (2019). Recent Advances in Depressive Disorder.
289. Gusmão, C. M. D., Maski, K., & Urion, D. K. (2014). Kleine-Levin Syndrome with Rapid Cycling - Case Report and Review of the Literature (P5.294). Neurology. https://doi.org/10.1212/wnl.82.10_supplement.p5.294
290. Gutiérrez-Achury, A. M., Vanegas-Vidal, M., Salazar-Díaz, L. I., & Arías, G. M. A. (2009). Factores farmacológicos y no farmacológicos que afectan la adherencia al tratamiento de los pacientes esquizofrénicos dados de alta en la Unidad de Salud Mental del Hospital Universitario de Neiva entre enero y junio del 2008. RFS Revista Facultad de Salud. https://doi.org/10.25054/rfs.v1i2.43
291. Gómez‐Revuelta, M., Blanco, L. S., Ruíz, M. J., Jenaro, G. P. D. S., Rodríguez, R. L., Olivares, O. P., & Morales, N. N. (2017). A Clinical review about differential diagnosis and comorbidities on premenstrual dysphoric disorder. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.577
292. Gümüş, H., İlnem, M. C., & Yener, F. (2006). Comorbid Gitelman Syndrome and Schizophrenia: A Case Report. Düşünen Adam: The Journal of Psychiatry and Neurological Sciences.
293. Haass, M., & Albus, C. (2014). Psychosoziale Faktoren bei Herzinsuffizienz: Mehr als eine Komorbidität?. Kardiologie up2date. https://doi.org/10.1055/s-0034-1365137
294. Haddad, P., & Chaudhry, I. B. (2012). Challenges in the management of early psychosis. Journal of Psychopharmacology. https://doi.org/10.1177/0269881111405365
295. Hafeza, M. J., Bourjia, H., & Sroura, H. (2020). Functional Neurological Deficit: one of the most controversial diagnosis- case report of a patient with paraplegia. International Journal of Case Reports. https://doi.org/10.28933/ijcr-2020-02-2305
296. Halbreich, U. (1997). Premenstrual dysphoric disorders: a diversified cluster of vulnerability traits to depression. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1997.tb09616.x
297. Hallengren, B. (1998). [Hypothyroidism--clinical findings, diagnosis, therapy. Thyroid tests should be performed on broad indications].. PubMed.
298. Halvorsen, J. G., & Metz, M. E. (1992). Sexual dysfunction, Part I: Classification, etiology, and pathogenesis.. PubMed.
299. Hammett, E., Fernandez-Carbonell, C., Crayne, C. B., Boneparth, A., Cron, R. Q., & Radhakrishna, S. M. (2020). Adolescent Sjogren’s syndrome presenting as psychosis: a case series. Pediatric Rheumatology. https://doi.org/10.1186/s12969-020-0412-8
300. Harisudan, D. S. (2018). Restless leg syndrome in general population of an urban area in India. Journal of Medical Science And clinical Research. https://doi.org/10.18535/jmscr/v6i11.129
301. Harris, T. (1991). Life Stress and Illness: The Question of Specificity. Annals of Behavioral Medicine. https://doi.org/10.1093/abm/13.4.211
302. Hasanah, L. (2015). Penyakit Skizoafektif dengan Tipe Depresi pada Wanita 34 Tahun. Jurnal Medula.
303. Hashempour, S., & Arbabi, M. (2016). Hyperaldosteronism and bipolar mixed episode: A case report. International Journal of Applied Behavioral Sciences. https://doi.org/10.22037/ijabs.v2i2.8085
304. Hatcher-Kay, C., & King, C. A. (2003). Depression and Suicide. Pediatrics in Review. https://doi.org/10.1542/pir.24.11.363
305. Hattori, I., & Miyauchi, T. (2005). [Relationship between the courses of clinical Features of patients with schizophrenia in adolescents and admission to psychiatric clinic].. PubMed.
306. Hausteiner‐Wiehle, C. (2014). Irritable bowel syndrome: Relations with functional, mental, and somatoform disorders. World Journal of Gastroenterology. https://doi.org/10.3748/wjg.v20.i20.6024
307. Hautzinger, M. (1993). Depressionen. Verhaltenstherapie. https://doi.org/10.1007/978-3-662-22591-2_63
308. Hawkes, M. A., & Hocker, S. E. (2021). Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0057
309. Healey, S. E., Kales, A., Monroe, L. J., Bixler, E. O., Chamberlin, K., & Soldatos, C. R. (1981). Onset of Insomnia: Role of Life-Stress Events1. Psychosomatic Medicine. https://doi.org/10.1097/00006842-198110000-00007
310. Hegyi, L., & Cagán, S. (1994). [Geriatric maladaptation syndrome].. PubMed.
311. Herz, M. I. (1985). Prodromal symptoms and prevention of relapse in schizophrenia.. PubMed.
312. Hirose, S. (2003). The Causes of Underdiagnosing Akathisia. Schizophrenia Bulletin. https://doi.org/10.1093/oxfordjournals.schbul.a007027
313. Hirschfeld, R. M. A., Calabrese, J. R., Frye, M. A., Lavori, P. W., Sachs, G., Thase, M. E., & Wagner, K. D. (2007). Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening.. PubMed.
314. Ho, M.-K., & Siu, A. Y.-C. (2010). High Altitude Medicine.
315. Hosseinbor, N., & Bakhshani, N.-M. (2014). Djinnati Syndrome in Baluchistan: The Role of Traumatic and Abuse Experiences on Individual Vulnerability. international journal high risk behaviors & addiction. https://doi.org/10.5812/ijhrba.23610
316. House, J. S. (1987). Chronic stress and chronic disease in life and work: Conceptual and methodological issues. Work & Stress. https://doi.org/10.1080/02678378708258494
317. Huang, C., Chen, Y., & Tsai, J. (2005). Paroxysmal Dyskinesia with Secondary Generalization of Tonic–clonic Seizures in Pseudohypoparathyroidism. Epilepsia. https://doi.org/10.1111/j.0013-9580.2005.39904.x
318. Huber, J., Drescher, U., & Asimakopoulou, K. (2009). Depression in people with type 2 diabetes.
319. Huda, A. S. (2019). Social factors and health. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0013
320. Huda, A. S. (2019). Spectrums of health. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0009
321. Hvolby, A., Jørgensen, J., & Bilenberg, N. (2005). [Sleeping disorders can imitate attention deficit/hyperactivity disorder].. PubMed.
322. Hybels, C. F., Blazer, D. G., & Steffens, D. C. (2006). Partial remission. A common outcome in older adults treated for major depression.. PubMed.
323. Häfele, M. (2001). Internistische Differenzialdiagnose bei unklaren Bewusstseinsstörungen in Verbindung mit synkopalen Zuständen oder epileptischen Anfällen. Aktuelle Neurologie. https://doi.org/10.1055/s-2001-15333
324. Hȧrd, E., Archer, T., & Hansen, S. (2003). Animal Models of Mental Retardation. Humana Press eBooks. https://doi.org/10.1385/0-89603-177-2:273
325. Ilin, V., & Vygovskiy, E. (2016). THE HYPOTHESIS OF THE INTERDEPENDENCE OF THE INCIDENCE OF MEDICAL PROFESSIONALS AND THE SYNDROME OF PROFESSIONAL-PSYCHOLOGICAL DISADAPTATION. Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук. https://doi.org/10.12737/23732
326. Iorga, M., Stârcea, I. M., Munteanu, M., & Sztankovszky, L.-Z. (2014). PSYCHOLOGICAL AND SOCIAL PROBLEMS OF CHILDREN WITH CHRONIC KIDNEY DISEASE.
327. Ishizuka, K., Shikino, K., Li, Y., Yokokawa, D., Tsukamoto, T., Yanagita, Y., Kojima, J., Yamashita, S., Noda, K., Uehara, T., & Ikusaka, M. (2023). The differential diagnosis of medical and psychogenic disease in primary care. Journal of General and Family Medicine. https://doi.org/10.1002/jgf2.661
328. Ivada, P. F., Ardani, I. G. A. I., Lesmana, C. B. J., Windiani, I. G. A. T., Adnyana, I. G. A. N. S., & Fithriyah, I. (2022). Quality of life of pediatric patients experiencing organic depressive disorder with Juvenile Idiopathic Arthritis. International journal of health & medical sciences. https://doi.org/10.21744/ijhms.v5n4.1994
329. Iversen, L. L., Iversen, S. D., Bloom, F. E., & Roth, R. H. (2009). Psychedelics. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195380538.003.0606
330. İbiloğlu, A. O., Atlı, A., Kaya, M. C., Baran, A. S., & Sır, A. (2016). Psychogenic Gait Disorder After a Stressful Life Event: Case Report. Turkiye Klinikleri Journal of Case Reports. https://doi.org/10.5336/caserep.2015-46732
331. Janas–Kozik, M., Dudek, D., Gałecki, P., Remberk, B., Lewandowska, A., & Tyszkiewicz‐Nwafor, M. (2025). Bipolar disorder in children, adolescents, and young adults. Part 1. Clinical symptoms and differential diagnosis. Recommendations under the patronage of the Executive Board of the Polish Psychiatric Association, National Consultants in the field of Psychiatry and National Consultants in Child and Adolescent Psychiatry. Psychiatria Polska. https://doi.org/10.12740/pp/191028
332. Janicak, P. G. (2014). Pharmacological Treatment of Psychosis. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg11
333. Jaspers, J. P. C. (2003). Lumpers versus splitters. Journal of Psychosomatic Obstetrics & Gynecology. https://doi.org/10.3109/01674820309074684
334. Jaya, M. A., & Syahrir, A. K. (2024). Psychodynamic Features of Depressed Patients with Dependent Personality Disorder and Hypokalemia: a Case Report. Action Research Literate. https://doi.org/10.46799/arl.v8i9.1901
335. Jefferson, J. W. (2001). Social Anxiety Disorder. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.v03n0102
336. Jenkins, J. M., & Oatley, K. (1998). The Development of Emotion Schemas in Children: Processes That Underlie Psychopathology. https://doi.org/10.1093/oso/9780195093216.003.0003
337. Jensen, J. B., Kumra, S., Thomarios, N., & Williams, R. C. (2009). Atypical Antipsychotics for Children and Adolescents With Schizophrenia-Spectrum Disorders.
338. Ji, J. (2012). Distinguishing subclinical (subthreshold) depression from the residual symptoms of major depression.. PubMed. https://doi.org/10.3969/j.issn.1002-0829.2012.05.007
339. Jibson, M. D., Glick, I. D., & Tandon, R. (2004). Schizophrenia and Other Psychotic Disorders. FOCUS The Journal of Lifelong Learning in Psychiatry. https://doi.org/10.1176/foc.2.1.17
340. Johnson, B. (2017). Somatic Symptom Disorders in Children.
341. Jongsma, A. E., & Berghuis, D. J. (2001). The Child Psychotherapy Progress Notes Planner.
342. Joshi, A., Shah, P. S., & Khanna, H. (2023). DIAGNOSTIC CHALLENGES OF HYPERSOMNIA IN AN INDIAN CHILD: A CASE REPORT. Indian Journal Of Applied Research. https://doi.org/10.36106/ijar/5301041
343. Judd, L. L., Rapaport, M. H., Paulus, M. P., & Brown, J. L. (1994). Subsyndromal symptomatic depression: a new mood disorder?. PubMed.
344. Jukić, M. K., Mimica, N., & Lucijanić, D. (2024). DEPRESSION IN ELDERLY PERSONS. Proceedings. https://doi.org/10.62598/9thicva.019
345. Juruena, M. F. (2012). Understanding subthreshold depression.. PubMed. https://doi.org/10.3969/j.issn.1002-0829.2012.05.009
346. Júnior, D. G. D., Toqueton, T. R., Antunes, B., Guimarães, A. C. C. M., Silva, T. F. D., Alves, A. P. D. P., Antunes, M. D. C., Pessoa, M. F. C., Adelino, M. F. C., & Santos, I. C. (2023). Evaluation and treatment of anxiety disorders in children and adolescents with endocrine diseases. https://doi.org/10.56238/seveniiimulti2023-251
347. Kanchanatawan, B., & Kasantikul, D. (2007). Antipsychotic-induced tardive movement disorders: a series of twelve cases.. PubMed.
348. Kanyengo, C. W. (2009). Zambia: The challenge of informing blind and deaf clients.
349. Kapfhammer, H., & Hippius, H. (1998). Special Feature: Pharmacotherapy in Personality Disorders. Journal of Personality Disorders. https://doi.org/10.1521/pedi.1998.12.3.277
350. Kaplan, H., Sadock, B. J., & Cancro, R. (1991). Comprehensive Textbook of Psychiatry/V.. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-114-9-823_8
351. Kaplan, H., Sadock, B. J., & Grebb, J. A. (1994). Kaplan and Sadock's synopsis of psychiatry : behavorial sciences, clinical psychiatry. Williams & Wilkins eBooks.
352. Kar, S. K. (2015). Psychiatric aspects of pediatric epilepsy: Focus on anxiety disorder. Medical Journal of Dr D Y Patil University. https://doi.org/10.4103/0975-2870.160777
353. Karaaslan, K., Gümüş, E., Gülcü, N., & Altunrende, B. (2008). Dirençli Jeneralize Status Epileptikusun Propofol ile Tedavisi (Olgu Sunumu). Duzce Medical Journal.
354. Karakatsoulis, G. N., Tsapakis, E.-M., & Fountoulakis, K. Ν. (2021). Clinical characteristics and treatment of treatment-resistant bipolar depression. Psychiatriki. https://doi.org/10.22365/jpsych.2021.048
355. Karakaya, İ., Öç, Ö., Şişmanlar, Ş. G., Memik, N. Ç., Çoşkun, A., & Ağaoğlu, B. (2007). Çok erken başlangıçlı çocukluk çağı şizofrenisi: Bir olgu sunumu. Anatolian Journal of Psychiatry.
356. Karatepe, H. T., Işık, H., Sayar, K., & Yavuz, F. (2010). Menstruation-related recurrent psychotic disorder: a case report. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. https://doi.org/10.5350/dajpn2010230409t
357. Katiri, R., Hall, D. A., & Kitterick, P. T. (2020). Developing an International Core Outcome Set for SSD Interventions. The Hearing Journal. https://doi.org/10.1097/01.hj.0000661612.83232.57
358. Katsarkas, A., & Noury, K. A. (1989). Sudden unilateral sensorineural hearing loss: a syndrome or a symptom?. PubMed.
359. Kelly, F. D. (2010). Adjustment Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0015
360. Kempster, P., Williams, D. R., Selikhova, M., Holton, J., Révész, T., & Lees, A. J. (2007). Patterns of levodopa response in Parkinson's disease: a clinico-pathological study. Brain. https://doi.org/10.1093/brain/awm142
361. Kessler, R. C., & Wang, P. S. (2008). The Descriptive Epidemiology of Commonly Occurring Mental Disorders in the United States. Annual Review of Public Health. https://doi.org/10.1146/annurev.publhealth.29.020907.090847
362. Ketterer, M. W., & Buckholtz, C. D. (1989). Somatization disorder.. PubMed.
363. Khaikin, Y., & Mercimek‐Andrews, S. (2016). STXBP1 Encephalopathy with Epilepsy.
364. Khan, Z., Mlawa, G., Mahdi, H., & Abumedian, M. (2023). Acute Psychosis Related to Primary Hyperparathyroidism in a Patient With Bipolar Disorder. Cureus. https://doi.org/10.7759/cureus.42567
365. Kim, H. A., Bisdorff, A., Bronstein, A. M., Lempert, T., Rossi-Izquierdo, M., Staab, J. P., Strupp, M., & Kim, J. (2019). Hemodynamic orthostatic dizziness/vertigo: Diagnostic criteria. Journal of Vestibular Research. https://doi.org/10.3233/ves-190655
366. Kim, J., Seo, J.-H., Kang, H.-S., Sung, W.-Y., & Jeong, D. (2007). One Case Report of Somatoform Disorder Patient with Dyspnea, Dysarthria and Gait Disturbance. Journal of Oriental Neuropsychiatry.
367. Knibb, J. A., & Hodges, J. R. (2005). Semantic Dementia: Losing the Meaning of Everything. Practical Neurology. https://doi.org/10.1111/j.1474-7766.2005.00316.x
368. Ko, J. Y., Wolicki, S. B., Barfield, W. D., Patrick, S. W., Broussard, C. S., Yonkers, K. A., Naimon, R., & Iskander, J. (2017). CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome. MMWR Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm6609a2
369. Kora, K., & Kaplan, P. (2008). [Hypomania/mania induced by cessation of antidepressant drugs].. PubMed.
370. Kotade, K. B., Pandit, B. S., Gaware, V. M., Dolas, R. T., Dhamak, K. B., Somwanshi, S. B., Nikam, V. K., & Khadse, A. N. (2011). KNOWING DEPRESSION AND PHARMACOLOGICAL, NON-PHARMACOLOGICAL APPROACHES FOR ITS TREATMENT.
371. Kovács, Z., Hegyi, G., & Szôke, H. (2022). Premenstruális szindróma és premenstruális dysphoriás zavar.. Orvosi Hetilap. https://doi.org/10.1556/650.2022.32496
372. Kovács, Z., Hegyi, G., & Szőke, H. (2022). Premenstruális szindróma és premenstruális dysphoriás zavar.. Orvosi Hetilap. https://doi.org/10.1556/650.2022.32489
373. Kowatch, R. A. (2007). Risperidone's 2 New Pediatric Indications: Approval Supports Antipsychotic Use in Children with Schizophrenia or Bipolar Disorder. Current psychiatry.
374. Koç, A. F., Bozdemir, H., Zorludemir, S., Almak, G., & Özeren, A. (2004). Lafora Body Disease: Clinical, Electrophysiological and Histopathological Findings. TURKISH JOURNAL OF MEDICAL SCIENCES.
375. Krystal, A. D., Edinger, J. D., & Wohlgemuth, W. K. (2013). Sleep and Circadian Rhythm Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt08
376. Krŭsteva, M., Krustev, B. P., & Mileva, S. A. (2000). Neonatal muscle hypotonia--an early manifestation of cerebral palsy.. PubMed.
377. Ku, B. D., Seo, S. W., Kim, E. J., Park, K., Suh, M. K., & Na, D. L. (2008). P3‐024: Diurnal bruxism in advanced Alzheimer's disease. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2008.05.1587
378. Kurokawa, T., Akazawa, K., Sakamoto, K., Hlaeda, Y., Kitamoto, I., Nose, Y., & Ueda, K. (1989). Developmental Retardation in Children with Refractory Epilepsy. Pediatrics International. https://doi.org/10.1111/j.1442-200x.1989.tb01302.x
379. Kučikienė, O., Lesauskaitė, V., Macijauskienė, J., Vainoras, A., Blaževičienė, A., Samėnienė, J., Alekna, V., Satkunskienė, D., Naudžiūnas, A., & Krutulytė, G. (2009). Dažniausi hospitalizuotų pagyvenusio amžiaus pacientų sveikatos sutrikimai.
380. Kızılkılıç, E. K., Kılboz, B. B., & Üçler, S. (2023). Syndrome of Transient Headache and Neurological Deficits with Cerebrospinal Fluid Lymphocytosis (HaNDL): A Case Report - Is there an Association with the COVID-19 Vaccine?. Annals of Indian Academy of Neurology. https://doi.org/10.4103/aian.aian_1002_22
381. Latta, F., & Cauter, E. V. (2003). Sleep and Biological Clocks. Handbook of Psychology. https://doi.org/10.1002/0471264385.wei0313
382. Lauriat, T. L., & Samson, J. (2015). Endocrine Disorders Associated with Psychological/Behavioral Problems. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199352722.013.32
383. Laynez, E. G., Bravo, B., González, S. M. B., & Portilla, N. O. (2024). The importance of including ADHD in the differential diagnosis in adults. About a case. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1707
384. Lee, E., Cheuk, J. T. Y., & Ungvári, G. S. (2009). A Patient with Chronic Schizophrenia Presenting with Multiple Deliberate Self-Harm and Genital Self-Mutilation. Hong Kong journal of psychiatry.
385. Lee, M. (2024). Cognitive function in first-episode psychosis : trajectories and biological markers. https://doi.org/10.69622/26936746
386. Lee, M. (2024). Cognitive function in first-episode psychosis : trajectories and biological markers. https://doi.org/10.69622/26936746.v1
387. Lee, S.-H., Song, D., Kim, B.-N., Joung, Y., Ha, E. H., Cheon, K., Shin, Y., Yoo, H. J., & Shin, D. (2009). Variability of Response Time as a Predictor of Methylphenidate Treatment Response in Korean Children with Attention Deficit Hyperactivity Disorder. Yonsei Medical Journal. https://doi.org/10.3349/ymj.2009.50.5.650
388. Lenzenweger, M. F. (2018). Schizotypy, schizotypic psychopathology and schizophrenia. World Psychiatry. https://doi.org/10.1002/wps.20479
389. Lepping, P., Huber, M., & Freudenmann, R. W. (2015). How to approach delusional infestation. BMJ. https://doi.org/10.1136/bmj.h1328
390. Levy, T., Silver, H., Soufer, R., Rouhandeh, A., Kolevzon, A., Buxbaum, J. D., & Siper, P. M. (2025). Adolescents and adults with FOXP1 syndrome show high rates of anxiety and externalizing behaviors but not psychiatric decompensation or skill loss. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2025.1526383
391. Levy, T., Silver, H., Soufer, R., Rouhandeh, A., Kolevzon, A., Buxbaum, J. D., & Siper, P. M. (2025). Adolescents and adults with FOXP1 syndrome show high rates of anxiety and externalizing behaviors but not psychiatric decompensation or skill loss. medRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2025.01.04.24318923
392. Leśniak, M., Bak, T. H., Czepiel, W., Seniów, J., & Członkowska, A. (2008). Frequency and Prognostic Value of Cognitive Disorders in Stroke Patients. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000162262
393. Lieb, K., Stoffers‐Winterling, J., & Dulz, B. (2014). Pharmakologische Behandlung von Borderline-Persönlichkeitsstörungen. Nervenheilkunde. https://doi.org/10.1055/s-0038-1627733
394. Lievre, J. L., Schweitzer, R., & Barnard, A. (2012). The subjective experience of negative symptoms: Characteristics of emotional withdrawal.
395. Lindenmayer, J., Khan, A., Harvey, P. D., Keefe, R. S., Liharska, L. E., Yavorsky, C., & Seddo, M. (2020). M120. IMPAIRED CLINICAL INSIGHT AS A PREDICTOR OF RELAPSE IN SCHIZOPHRENIA. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbaa030.432
396. Lis‐Święty, A., Brzeźińska-Wcisło, L., & Arasiewicz, H. (2016). Neurological abnormalities in localized scleroderma of the face and head: a case series study for evaluation of imaging findings and clinical course. International Journal of Neuroscience. https://doi.org/10.1080/00207454.2016.1244823
397. Liu, M., Zhang, S., Hao, Y., & Zheng, H. (2012). Paroxysmal Kinesigenic Dyskinesia as the Initial Symptom of Hashimoto Encephalopathy. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/j.1755-5949.2012.00297.x
398. Llorca, P., Chéreau, I., Brousse, G., & Schawn, R. (2004). Troubles psychiatriques d'origine toxique ou alimentaire. EMC - Psychiatrie. https://doi.org/10.1016/j.emcps.2004.04.003
399. Lockhart, P. J. (2001). Fetal alcohol spectrum disorders for mental health professionals - a brief review. Current Opinion in Psychiatry. https://doi.org/10.1097/00001504-200109000-00007
400. Loosen, P. T. (1994). Cushingʼs Syndrome and Depression. The Endocrinologist. https://doi.org/10.1097/00019616-199409000-00008
401. Lopez, R. (2014). Quelle est l’évolution sémiologique du trouble déficit d’attention avec hyperactivité après 60 ans ?. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2014.09.286
402. Loranger, A. W. (1984). Schizophrenia and Age Considerations-Reply. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1984.01790190093015
403. Lukačević, M. (2016). Depresivnost djece u primarnom obrazovanju.
404. Lund, A. M., Sandgren, G., & Knudsen, F. (1998). [Shaken baby syndrome].. PubMed.
405. Ma, J., & Junqué, C. (2001). [Criminal behavior after orbitofrontal lesion].. PubMed.
406. Machado, M. D. O. S., Carmo, A., & Antoniuk, S. A. (2018). Febrile seizure in childhood: A review of the main concepts. Residência Pediátrica. https://doi.org/10.25060/residpediatr-2018.v8s1-03
407. Macneil, C., Hasty, M., Conus, P., Berk, M., & Scott, J. (2009). Social rhythm regulation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511757389.008
408. MacPherson, H. A. (2019). More than medication: The importance of family treatments for pediatric bipolar disorder. The Brown University Child and Adolescent Behavior Letter. https://doi.org/10.1002/cbl.30433
409. Madrid, P. A., Grant, R., Reilly, M. J., & Redlener, N. B. (2006). Challenges in Meeting Immediate Emotional Needs: Short-term Impact of a Major Disaster on Children's Mental Health: Building Resiliency in the Aftermath of Hurricane Katrina. PEDIATRICS. https://doi.org/10.1542/peds.2006-0099u
410. Madruga, M. L. L. H., Melo, G. B., Martins, J. M., Aranha, R. E. L. D. B., Marinho, J. C. R. L., Alves, N. T., Estudo, E., Revisão, U., & Literatura, D. (2018). Estudo Eletroencefalográfico De Indivíduos Com Dor Crônica Decorrente Da Fibromialgia: Uma Revisão Da Literatura. Scientific Research and Reviews. https://doi.org/10.28933/srr-2018-06-28100
411. Mahdi, E. N. O. E., Naguib, R. M., Wahdan, M., Mahmoud, M. M., & Atallah, M. M. (2024). Chronic Spontaneous Urticaria Severity in Association with the Severity of Anxiety and Depression among Egyptian Patients. QJM. https://doi.org/10.1093/qjmed/hcae070.298
412. Maksimova, M. Y., & Kotlyar, Y. А. (2024). Kleine—Levin syndrome. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro2024124071169
413. Malenfant, M., Tremblay, S., Laurin, D., & Lefèbvre, J. (2008). L'utilisation du citalopram pour traiter l'agitation et les symptômes psychotiques chez les patients souffrant de démence.
414. Malikova, M. A. (2024). Schizophrenia: Studying the Influence of Various Factors on the Occurrence and Progression of Disease. European Journal of Medical and Health Research. https://doi.org/10.59324/ejmhr.2024.2(6).29
415. Manakil, J. F. (2012). Depression and periodontal health.
416. Manica, A., Leães, C. G. S., Frey, B. N., & Juruena, M. F. (1999). The role of depression in coronary artery disease. Arquivos Brasileiros de Cardiologia. https://doi.org/10.1590/s0066-782x1999000800012
417. Manniche, C., Hauge, E., Voss, A., Mašić, D., Johannsen, F. E., Johannsen, F. E., Voss, A., Mašić, D., Mašić, D., Voss, A., & Johannsen, F. E. (2018). Patient med rygsmerter. Research Portal Denmark.
418. Mansoor, M., Khan, N. R., & Shafique, A. (2022). Prolonged psychosis before onset of neurological symptoms; an atypical clinical manifestation of Huntington’s disease. Pakistan Journal of Neurological Sciences. https://doi.org/10.56310/pjns.v17i01.151
419. Maramis, M. M. (2009). Mendiagnosis Gangguan Bipolar pada Fase Depresi sejak dini.
420. Mardaga, S., Bassir, M. A., Bracke, J., Dutilleux, A., & Born, J. D. (2017). [Which psychiatric symptoms must raise suspicion about a possible brain tumor ?]. PubMed.
421. Maremmani, I., Pacini, M., & Maremmani, A. G. I. (2023). Chronic Psychosis in Dual Disorder Heroin Use Disorder Patients. https://doi.org/10.1007/978-3-031-30093-6_4
422. Marinković, D., Marinković, O., Totić, S., Marić, N. P., Đorđević, A., Jašović‐Gašić, M., & Paunović, V. (2001). Bipolar affective disorder inheritance and genetic anticipation. Engrami.
423. Markham, R. A., & Watts, S. (2005). Etiology of Depression in Children.. Journal of instructional psychology.
424. Marks, D. J., Trampush, J. W., & Chacko, A. (2010). Attention deficit hyperactivity disorder in children and adolescents. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511674815.008
425. Marneros, A., & Pillmann, F. (2004). Defining the brief, acute and transient psychotic disorders: the polymorphic psychotic core. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544002.012
426. Martins-Correia, L., & Salgado, H. (2014). Williams syndrome and psychosis: a case report. Journal of Medical Case Reports. https://doi.org/10.1186/1752-1947-8-49
427. Martínez, A. R., Argüelles, P. P., Cucurella, M. M., Llort, A. J., Camacho, J. A., & Plana, J. C. (2008). Manifestaciones neurológicas en el síndrome hemolítico urémico. Revista de Neurología. https://doi.org/10.33588/rn.4704.2008249
428. Martı́n, M. Á., Remschmidt, H., Schulz, E., Warnke, A., & Trott, G.-E. (1994). Childhood-Onset Schizophrenia: History of the Concept and Recent Studies. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/20.4.727
429. María, A., Sancho, R., & Pita, B. L. (2005). Trastornos de ansiedad en la infancia y en la adolescencia.
430. Marín, H., Menza, M., & Dobkin, R. D. (2007). Parkinson's Symptoms or Depression? Look for Clinical Signs: How to Sort through Overlapping Symptoms Using DSM-IV-TR Diagnostic Criteria. Current psychiatry.
431. Marčić, M., Marčić, L., & Titlić, M. (2018). A Case of Kleine-Levin Syndrome: Diagnostic and Therapeutic Challenge.. PubMed.
432. Masi, G., Favilla, L., & Millepiedi, S. (2000). The Kleine-Levin Syndrome as a Neuropsychiatric Disorder: A Case Report. Psychiatry. https://doi.org/10.1080/00332747.2000.11024898
433. Masodkar, K., Manning, S., & McMahon, T. (2016). Bipolar II Disorder Masked by Substance Use. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.15l01813
434. Maududi, T., Mall, S. K., & Mall, G. (2009). A 50-year-old Woman Who Hears Voices. Psychiatric Annals. https://doi.org/10.3928/00485713-20091022-03
435. Mauracher, L., Serebriakova, J., Niederstätter, H., Parson, W., Schurr, T., & Deisenhammer, E. (2024). Subclinical hypomanic experiences in young adults after sleep deprivation are independent of depressive disorders, chronotype or 5-HTTLPR polymorphism. The World Journal of Biological Psychiatry. https://doi.org/10.1080/15622975.2024.2382697
436. Mauri, M. C. (2016). Drug Induced Psychosis or Schizophrenia?. Dual Diagnosis Open Access. https://doi.org/10.21767/2472-5048.100011
437. Mayo‐Wilson, E., Montgomery, P., & Dennis, J. A. (2007). PROTOCOL: Personal assistance for children and adolescents (0‐18) with both physical and intellectual impairments. Campbell Systematic Reviews. https://doi.org/10.1002/cl2.41
438. Mazet, P., Bouquerel, G., & Millier, C. L. (1981). [Psychological and psychiatric emergencies in child and adolescent. Specificity and diversity of the possible situations and responses (author's transl)].. PubMed.
439. Mazzoni, P., Kimhy, D., Khan, S., Posner, K., Maayan, L., Eilenberg, M., Walsh‐Messinger, J., Kestenbaum, C. J., & Corcoran, C. M. (2009). Childhood Onset Diagnoses in a Case Series of Teens at Clinical High Risk for Psychosis. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2008.0105
440. Mc, M.-S. (1993). [Post-traumatic stress syndrome in children].. PubMed.
441. McCullough, J. P. (2010). Cognitive Behavioral Analysis System of Psychotherapy. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0192
442. McManus, I. C., Stubbings, G. F., & Martín, N. P. D. C. (2006). Stigmatization, Physical Illness and Mental Health in Primary Ciliary Dyskinesia. Journal of Health Psychology. https://doi.org/10.1177/1359105306063320
443. Medina, A. B., Roniger, D. D. G., Alonzo, G. M., & Genchi, A. J. (2012). Síndrome de piernas inquietas en comorbilidad con trastornos psiquiátricos y enfermedad médica: un caso ilustrativo. Psiquis - Hospital Psiquiátrico Fray Bernardino Alvarez.
444. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). [Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly].. PubMed.
445. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). Diagnóstico y tratamiento del insomnio en el adulto mayor.
446. Mehta, P., & Rani, G. S. (2020). Identification and Early Intervention of Bipolar Disorder in Adolescence and Adults. International Journal of Engineering and Advanced Technology. https://doi.org/10.35940/ijeat.b3637.029320
447. Melo-Dias, C., Apóstolo, J., & Cardoso, D. (2014). Effectiveness of progressive muscle relaxation training for adults diagnosed with schizophrenia: a systematic review protocol. The JBI Database of Systematic Reviews and Implementation Reports. https://doi.org/10.11124/jbisrir-2014-1639
448. Mendelevich, В. D., Sitdikov, G. A., & Abakarov, R. R. (2024). Clinical mixed dissociative and post-traumatic stress disorders in a 10-year-old boy after a traffic accident. Neurology Bulletin. https://doi.org/10.17816/nb625486
449. Menéndez, S. F., González, J. M. G., Antuña, V. Á., & Bobes, J. (2016). La demencia del rey Fernando VI y el año sin rey. Revista de Neurología. https://doi.org/10.33588/rn.6211.2016040
450. Merino, N., Fumero, M., Gaviño, M. E., & García‐Bustinduy, M. (2022). Psychological Impact of Vitiligo. IntechOpen eBooks. https://doi.org/10.5772/intechopen.106909
451. Mertens, V., Ballart, L. V., Block, C. D., Greef, K. D., Vandewoude, M., Hans, G., Perkisas, S., & Moorkens, G. (2023). Added Value of Geriatric Consultation on the Emergency Department to Detect Primary Hyperparathyroidism in the Elderly Presenting as Frail Phenotype: Review of the Literature and A Case Report. European Journal of Geriatrics and Gerontology. https://doi.org/10.4274/ejgg.galenos.2023.2023-2-3
452. Mewasingh, L. (2014). Febrile seizures.. PubMed.
453. Mewes, R., & Rief, W. (2008). Somatoforme Störungen und Hypochondrie. Psychiatrie und Psychotherapie up2date. https://doi.org/10.1055/s-2007-986338
454. Meyer, J. S., & Hamel, A. F. (2014). Models of Stress in Nonhuman Primates and Their Relevance for Human Psychopathology and Endocrine Dysfunction. ILAR Journal. https://doi.org/10.1093/ilar/ilu023
455. Meza, E. G. L., Téllez, F. C., Guevara, I. M. A., González-Aragón, M. D. C. F., & Calderón, L. Á. R. (2003). Estado epiléptico no convulsivo asociado a enfermedad de Lafora: presentación de dos casos. Revista de Neurología. https://doi.org/10.33588/rn.3710.2003290
456. Michal, M. (2022). Depersonalization/Derealization Disorder. Routledge eBooks. https://doi.org/10.4324/9781003057314-29
457. Miklowitz, D. J., & Chang, K. (2008). Prevention of bipolar disorder in at-risk children: Theoretical assumptions and empirical foundations. Development and Psychopathology. https://doi.org/10.1017/s0954579408000424
458. Miklowitz, D. J., & Johnson, S. L. (2009). Social and familial factors in the course of bipolar disorder: Basic processes and relevant interventions.. Clinical Psychology Science and Practice. https://doi.org/10.1111/j.1468-2850.2009.01166.x
459. Miletić, V., & Relja, M. (2009). Dystonia in HIV positive patient.
460. Miletto, G., & Julou, M. (1981). [Tiapride in the treatment of neurological and psychiatric disorders in the elderly (author's transl)].. PubMed.
461. Miller, F. T., Abrams, T., Dulit, R., & Fyer, M. R. (1993). Psychotic Symptoms in Patients With Borderline Personality Disorder and Concurrent Axis I Disorder. Psychiatric Services. https://doi.org/10.1176/ps.44.1.59
462. Miller, K. B. (1987). Does the Dexamethasone Suppression Test Relate to Subtypes, Factors, Symptoms, or Severity?. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1987.01800210013002
463. Miller, K. J., & Castellanos, F. X. (1998). Attention Deficit/Hyperactivity Disorders. Pediatrics in Review. https://doi.org/10.1542/pir.19.11.373
464. Miller, M. W., Marx, B. P., & Keane, T. M. (2010). Posttraumatic Stress Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0699
465. Mir, J. A., Mushtaq, B., & Mushtaq, O. A. (2022). Clinical case report on bipolar affective disorder, mania. IP Journal of Paediatrics and Nursing Science. https://doi.org/10.18231/j.ijpns.2022.007
466. Mirawati, D. K. (2018). Managing antiepileptic drug, Starting, Changing and Stopping AED’s.
467. Mitchell, P. B., Goodwin, G. M., Johnson, G. F., & Hirschfeld, R. M. A. (2008). Diagnostic guidelines for bipolar depression: a probabilistic approach. Bipolar Disorders. https://doi.org/10.1111/j.1399-5618.2007.00559.x
468. Miyata, H., Kono, J., & Yanagita, T. (2005). Clinical features of nicotine dependence.
469. MM, B., Islam, S., Nh, S., Rahman, M., & Bari, M. (2016). None. MOJ Orthopedics & Rheumatology. https://doi.org/10.15406/mojor.4.1
470. Modigh, K., Berggren, U., & Sehlin, S. (1998). [High risk for children with DAMP/ADHD to become addicts later in life].. PubMed.
471. Mohan, F. S. C. (2006). Practice Tips. Clinical sign could screen for depressive symptoms.. PubMed.
472. Molière, F. (2014). Comorbidités psychiatriques et résistance thérapeutique. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2014.09.052
473. Monteiro, M. I., Ferreira, A., Grebe, H., Gomes, L., & Costa, M. M. D. (2016). Psiquiátrico, aditivo ou orgânico:  um desafio nos adolescentes. DOAJ (DOAJ: Directory of Open Access Journals).
474. Montes, A. B., & Rey, J. A. (2009). Iloperidone (Fanapt): An FDA-Approved Treatment Option for Schizophrenia. P & T.
475. Montgomery, S., Bebbington, P., Cowen, P. J., Deakin, J., Freeling, P., Hallström, C., Katona, C., King, D. S., Leonard, B., Levine, S., Phanjoo, A. L., Peet, M., Thompson, C. M., & Thompson, C. M. (1993). Guidelines for treating depressive illness with antidepressants: A statement from the British Association for Psychopharmacology. Journal of Psychopharmacology. https://doi.org/10.1177/0269881193007001041
476. Monzée, J., & Dionne, A.-I. (2025). Improving the Psychosocial Assessment of Young People with ADHD: Clinical and Ethical Issues from the Quebec Experience (I). Medical Research Archives. https://doi.org/10.18103/mra.v13i6.6536
477. Moraiti, V., & Porfyri, G. N. (2024). Schizophrenia and Risk of Dementia: A Literature Review.. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1583
478. Moreno, M. A. (2010). Attention-Deficit/Hyperactivity Disorder. Archives of Pediatrics and Adolescent Medicine. https://doi.org/10.1001/archpediatrics.2010.65
479. Morin, C. (2009). [Sense of personal identity and focal brain lesions].. PubMed. https://doi.org/10.1684/pnv.2009.0156
480. Morita, H., Ideshita, H., Yoshinaga, J., Sasaki, T., & Hikiji, A. (1980). [A study on mental symptoms developing during the treatment of Parkinson's disease (author's transl)].. PubMed.
481. Moroianu, L.-A., Ciubară, A. B., Ciubară, A., & Nechita, A. (2017). Acute Psychotic Episode in Psychostimulant Drug Addicted Teenager. American Journal of Psychiatry and Neuroscience. https://doi.org/10.11648/j.ajpn.s.2017050601.33
482. Morylowska-Topolska, J., Ziemiński, R., Molas, A., Gajewski, J., Flis, M., Stelmach, E., & Karakuła‐Juchnowicz, H. (2016). Schizophrenia and anorexia nervosa – reciprocal relationships. A literature review. Psychiatria Polska. https://doi.org/10.12740/pp/onlinefirst/63514
483. Moser, G. (2009). Reizdarmsyndrom und Psychosomatik. Journal für Ernährungsmedizin.
484. Mosolov, S. (2020). Diagnosis and Treatment of Depression in Patients with Schizophrenia. Consortium Psychiatricum. https://doi.org/10.17650/2712-7672-2020-1-2-29-42
485. Mossaheb, N., Schloegelhofer, M., Schaefer, M., Fusar‐Poli, P., Smesny, S., McGorry, P. D., Berger, G., & Amminger, G. P. (2012). Long-Chain Omega-3 Fatty Acids and Psychotic Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-62703-215-5_9
486. Moster, R. L., Siever, L. J., & Frangou, S. (2016). Schizophrenia Spectrum and Other Psychotic Disorders. https://doi.org/10.1002/9781118654231.ch15
487. Mota, D. C. M., Barbosa, M., Silva, R. R. D., & Ribeiro, L. H. (2020). SÍNDROME DEL OÍDO MUSICAL Y DEPRESIÓN PSICÓTICA: UN CASO DE DOBLE ACTIVIDAD ALUCINATORIA AUDITIVA..
488. Moudden, S. E., Chaouki, S., Abourazzak, S., & Hida, M. (2023). RETT SYNDROME: A CASE REPORT. International Journal of Advanced Research. https://doi.org/10.21474/ijar01/17850
489. Moukaddam, N., & Shah, A. A. (2016). Treatment-Resistant Depression: An Overview. Psychiatric Annals. https://doi.org/10.3928/00485713-20160215-01
490. Moukaddam, N., Cavazos, E., Nazario, M., Murtaza, S. T., & Shah, A. A. (2019). Depression and Its Impact on Adolescents. Psychiatric Annals. https://doi.org/10.3928/00485713-20190506-01
491. Munro, A. (1999). ‘Paranoid spectrum’ illnesses which should be included in the category of delusional disorder. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544095.010
492. Muskin, P. R. (2014). DSM-5 Self-Exam Questions: Test Questions for the Diagnostic Criteria.
493. Mut, E. A., Pălădoiu, C., & Stănescu, M. (2021). Somatoform and conversion disorders as psychological defences. Journal of Educational Sciences & Psychology. https://doi.org/10.51865/jesp.2021.1.19
494. Mw, H., Eg, G., Hj, B., & Weel, C. V. (1997). [Chronic fatigue syndrome].. PubMed.
495. Myers, K. A., & Scheffer, I. E. (2016). GRIN2A-Related Speech Disorders and Epilepsy. University of Washington, Seattle eBooks.
496. Müller‐Spahn, F., & Hock, C. (1994). Clinical Presentation of Depression in the Elderly. Gerontology. https://doi.org/10.1159/000213615
497. Nadeem, Z., McIntosh, A. M., & LAWRIE, S. M. (2004). Schizophrenia. Evidence-Based Mental Health. https://doi.org/10.1136/ebmh.7.1.2
498. Nafiaa, H., Benchikhi, L., & Ouanass, A. (2022). Morphological Abnormalities in Schizophrenia: Systematic Review. SAS Journal of Medicine. https://doi.org/10.36347/sasjm.2022.v08i05.005
499. Nahler, G. (2009). labelling phenomenon. Dictionary of Pharmaceutical Medicine. https://doi.org/10.1007/978-3-211-89836-9_767
500. Naidu, B. M. (2016). Drug Abuse in India. International journal of research in social sciences.
501. Nakata, C., Ito, M., & Okazaki, M. (2008). Epilepsy with Severely Higher Brain Dysfunction Developing during Adolescence: A Case Report. Journal of the Japan Epilepsy Society. https://doi.org/10.3805/jjes.26.26
502. Nanagas, M. T. (2011). Bipolar Disorders. Pediatrics in Review. https://doi.org/10.1542/pir.32.11.502
503. Nandi, K., Sarkar, S., Bakshi, P., Chandra, A. C., Chakraborty, A., Mondal, S., Biswas, A., Bera, K., Sen, D. J., & Saha, D. (2005). COVID-19 & CO-MORBIDITY: DEMONIC FORCES THAT SUPRESS THE CIVILIZATION. World Journal of Pharmaceutical and life sciences.
504. Narang, T., Garima, & Singh, S. M. (2016). Psychosexual disorders and dermatologists. Indian Dermatology Online Journal. https://doi.org/10.4103/2229-5178.182349
505. Narayan, S. K., Sivaprasad, P., Sahoo, R. N., & Bhuvaneswari, V. (2008). Teaching Video Neuro <i>Image</i> : Chvostek sign with Fahr syndrome in a patient with hypoparathyroidism. Neurology. https://doi.org/10.1212/01.wnl.0000336974.93499.ad
506. Neil, W., Curran, S., & Wattis, J. (2003). Antipsychotic prescribing in older people. Age and Ageing. https://doi.org/10.1093/ageing/afg061
507. Neufeld, K. J., Needham, D. M., Oh, E. S., Wilson, L. M., Nikooie, R., Zhang, A., Koneru, M., Balagani, A., Singu, S., Aldabain, L., & Robinson, K. A. (2019). Antipsychotics for the Prevention and Treatment of Delirium. https://doi.org/10.23970/ahrqepccer219
508. Nevšímalová, S., Havlová, M., Tauberová, A., & Příhodová, I. (2005). [Alternating hemiplegia of childhood (AHC)].. PubMed.
509. Newcorn, J. H. (2008). Co-morbidity in Adults with ADHD. CNS Spectrums. https://doi.org/10.1017/s1092852900003199
510. Nielsen, J. F., Klemar, B., Hansen, H., & Sinkjær, T. (1995). A new treatment of spasticity with repetitive magnetic stimulation in multiple sclerosis.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.58.2.254-a
511. Nishihara, K., Kinoshita, H., Kurotaki, N., Ozawa, H., & Imamura, A. (2010). Could subclinical hypothyroidism cause periodic catatonia with delusional misidentification syndrome?. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.2010.02080.x
512. Norton, G. R., Block, G. W., & Malan, J. (1991). The Psychopathology of Panicking and Non-Panicking Male Alcoholics. Alcoholism Treatment Quarterly. https://doi.org/10.1300/j020v08n03_06
513. Noyes, R. (2014). Course and Outcome of Hypochondriasis and Health Anxiety. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199996865.003.0007
514. Ochoa, A., Corgo, S. R., Pey, M. A., Cristobal, M., Vicente, E. P., Campos, A., Gordillo, C., Ibañez, A. C. C., Astorga, A. Á., & Huelva, P. A. (2023). Chronic disease (CD) during transition from child to adult.Psychopathological consequences and coping strategies. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.1565
515. Ohi, K., Hashimoto, R., Sugai, F., Yasuda, Y., Tagami, S., Takamura, H., Morihara, T., Okochi, M., Tanaka, T., Kudo, T., Sakoda, S., & Takeda, M. (2008). Difficulty identifying spinocerebellar ataxia 17 from preceding psychiatric symptoms. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.2008.01860.x
516. Olubusola, J. (2012). Therapeutic Exercises in the Management of Non-Specific Low Back Pain. InTech eBooks. https://doi.org/10.5772/35856
517. Onochie, E., & Verghese, J. (2025). A Case of Depersonalization-Derealization Disorder. BJPsych Open. https://doi.org/10.1192/bjo.2025.10752
518. Oruç, G. A., & Gültekin, B. K. (2018). The critical period in patients with psychosis: "Duration of Untreated Psychosis" and social determinants. Journal of Clinical Psychiatry. https://doi.org/10.5505/kpd.2018.38258
519. Osterman, J. E., Erdos, B. Z., Oldham, M., & Ivkovic, A. (2010). Antidepressant Treatments in PTSD. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-435-7_7
520. O’Dwyer, A.-M., & Campion, M. (2022). Anxiety and obsessional disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198867135.003.0008
521. Pablo, G. S. D. (2018). Mental Capacity and Decision Making in Bipolar Disorder. Peer Reviewed Journal of Forensic & Genetic Sciences. https://doi.org/10.32474/prjfgs.2018.03.000152
522. Pachana, N. A., Laidlaw, K., Ceglowski, J., Dios, L. V. D., & Depp, C. A. (2014). Psychosis in Older Adults. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199663170.013.041
523. Padmos, R. C. (2009). Inflammatory Monocytes in Bipolar Disorder and Related Endocrine Autoimmune Diseases.
524. Palmer, B. W., McClure, F. S., & Jeste, D. V. (2001). Schizophrenia in Late Life: Findings Challenge Traditional Concepts. Harvard Review of Psychiatry. https://doi.org/10.1080/10673220127883
525. Pandit, M. S., Gupta, A., Mathur, P., Sharma, M., & Garg, M. (2016). JOURNAL OF PEDIATRIC CRITICAL CARE. JOURNAL OF PEDIATRIC CRITICAL CARE. https://doi.org/10.21304/2016.0302.00123
526. Panza, F., Frisardi, V., Capurso, C., D’Introno, A., Colacicco, A. M., Seripa, D., Pilotto, A., Vendemiale, G., Capurso, A., & Solfrizzi, V. (2009). POSSIBLE PREDICTORS OF VASCULAR COGNITIVE IMPAIRMENT–NO DEMENTIA. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2009.02236.x
527. Paprocka, J., Jamroz, E., Wackermann-Ramos, A., Sokół, M., & Marszał, E. (2005). [Neurological picture and 1H MRS in 4 children with hypoparathyroidism].. PubMed.
528. Papuc, I., LĂCĂTUŞ, R., Timen, A. M., Coşa, L., & Purdoiu, R. C. (2007). CANINE ANXIETY SINDROME BY DOG - OWNER SEPARATION TREATMENT. Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca Veterinary Medicine. https://doi.org/10.15835/buasvmcn-vm:64:1-2:2397
529. Parano, E., Pappalardo, X. G., Pavone, P., Ruggieri, M., & Cavallaro, S. (2016). Child Abuse Syndrome (CAS): A Newly Recognized Distinct Entity. The Open Neurology Journal. https://doi.org/10.2174/1874205x01610010030
530. Pareja, J. A., Cuadrado, M. L., García‐Morales, I., Gil‐Nagel, A., & Franch, O. (2008). Hypnagogic Behavior Disorder: Complex Motor Behaviors During Wake–Sleep Transitions in 2 Young Children. Journal of Child Neurology. https://doi.org/10.1177/0883073808314964
531. Park, J. S., Belfort, M. A., & Norwitz, E. R. (2001). Pathogenesis and treatment of eclampsia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545634.030
532. Parkinson, J. T., Foley, É. M., Jadon, D. R., & Khandaker, G. M. (2020). Depression in patients with spondyloarthritis: prevalence, incidence, risk factors, mechanisms and management. Therapeutic Advances in Musculoskeletal Disease. https://doi.org/10.1177/1759720x20970028
533. Parmeggiani, A., Posar, A., Antolini, C., Scaduto, M. C., Santucci, M., & Giovanardi‐Rossi, P. (2007). Epilepsy in Patients With Pervasive Developmental Disorder Not Otherwise Specified. Journal of Child Neurology. https://doi.org/10.1177/0883073807306265
534. Patel, A., & Patel, K. (2016). A Case of Childhood Onset Obsessive Compulsive Disorder Presented as School Refusal for a Year. International Journal of Indian Psychology. https://doi.org/10.25215/0401.012
535. Pathak, A., Rai, J., Rai, N., Singh, R., & Bhatt, G. (2023). AB1367 EFFECTIVENESS OF REHABILITATION STRATEGIES IN PRIMARY FIBROMYALGIA SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS. https://doi.org/10.1136/annrheumdis-2023-eular.295
536. Pathology, S.-L., Girten, D., & Lackey, C. (2014). Working with Children with Mental Health Issues.
537. Pavone, P., Corsello, G., Ruggieri, M., Marino, S., Marino, S. D., & Falsaperla, R. (2018). Benign and severe early-life seizures: a round in the first year of life. The Italian Journal of Pediatrics/Italian journal of pediatrics. https://doi.org/10.1186/s13052-018-0491-z
538. Paw, H., & Shulman, R. (2014). Management of status epilepticus. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781316182673.042
539. Pearce, J. (1987). Symptom Management in Multiple Sclerosis. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.50.9.1247
540. Pedrós, A., Martí‐Almor, J., Gutiérrez, G., Tenías, J. M., & Ruescas, S. (2009). [Two-year diagnostic stability and prognosis in acute psychotic episodes].. PubMed.
541. Peitl, M. V., Prološčić, J., Zelić, S. B., Skarpa-Usmiani, I., & Peitl, V. (2011). Symptoms of agitated depression and/or akathisia.. PubMed.
542. Perera, H., Wijesekara, J., & Hewage, U. (2014). Periodic changes in behaviour in a child with pseudohypoparathyroidism. Ceylon Medical Journal. https://doi.org/10.4038/cmj.v46i2.6501
543. Perrin, J. M., Gnanasekaran, S. K., & Delahaye, J. (2012). Psychological Aspects of Chronic Health Conditions. Pediatrics in Review. https://doi.org/10.1542/pir.33.3.99
544. Perrino, C. D. D. (2009). Prevalencia de síntomas afectivos en una cohorte de pacientes con trastorno bipolar: Un estudio de seguimiento prospectivo hasta 18 meses.
545. Person, C., Atkinson, J. H., Young, C., Deitch, D. A., & Treisman, G. J. (2005). Psychiatric disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198526100.003.0048
546. Perugi, G. (2008). Comorbidity and treatment issues in juvenile bipolar disorder. Annals of General Psychiatry. https://doi.org/10.1186/1744-859x-7-s1-s43
547. Perugi, G. (2010). Cyclothymic temperament and/or borderline personality disorder. Annals of General Psychiatry. https://doi.org/10.1186/1744-859x-9-s1-s77
548. Pfeiffer, E., Allroggen, M., & Sachser, C. (2022). Misophonie im Kindes- und Jugendalter: Eine narrative Übersichtsarbeit. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie. https://doi.org/10.1024/1422-4917/a000885
549. Philips, S., & Grindrod, C. (2023). Mental health. https://doi.org/10.1002/9781119099727.ch18
550. Phillips, M. M. (1990). The Alcohol Drinking History.
551. Pies, R. W. (2007). Is It Bipolar Depression? 'WHIPLASHED' Aids Diagnosis. Current psychiatry.
552. Pilling, S., Baron‐Cohen, S., Megnin‐Viggars, O., Lee, R., & Taylor, C. V. (2012). Recognition, referral, diagnosis, and management of adults with autism: summary of NICE guidance. BMJ. https://doi.org/10.1136/bmj.e4082
553. Plaza-González, S., Zabala-Baños, M. D. C., Astasio-Picado, Á., & Jurado‐Palomo, J. (2022). Psychological and Sociocultural Determinants in Childhood Asthma Disease: Impact on Quality of Life. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph19052652
554. Politis, M., Wu, K., Molloy, S., Bain, P. G., Chaudhuri, К. R., & Piccini, P. (2010). Parkinson's disease symptoms: The patient's perspective. Movement Disorders. https://doi.org/10.1002/mds.23135
555. Pomerantz, J. M. (2008). Early Antidepressant Treatment Is Effective for Post-Stroke Depression.
556. Pontari, M. A. (2020). Definition and epidemiology of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). https://doi.org/10.5680/lhuii000050
557. Pope, H. G., McElroy, S. L., Keck, P. E., Hudson, J. I., Faedda, G. L., & Swann, A. C. (1992). Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. American Journal of Psychiatry. https://doi.org/10.1176/ajp.149.12.1633
558. Portillo-Pérez, R. M., Molero, N. P. D., Medrano-León, E. E., Morales-Rincón, G., & Peña, J. (2025). Condiciones comórbidas del síndrome de West y autismo: Reporte de 5 casos.. Investigación Clínica. https://doi.org/10.54817/ic.v66n3a08
559. Potart, C., Pellerin, J., & Pinquier, C. (2003). [Hysteria and aging].. PubMed.
560. Prager, L. M. (2009). Depression and Suicide in Children and Adolescents. Pediatrics in Review. https://doi.org/10.1542/pir.30.6.199
561. Prasetya, E. C., Subagyo, R., Mahyuddin, M. H., Haniifah, U., Rafida, M., Hamida, A., Ramzy, M., & Prasetya, M. T. (2022). Continuously Paranoid Schizophrenia in Young Man: A Case Report. Asian Australasian Neuro and Health Science Journal (AANHS-J). https://doi.org/10.32734/aanhsj.v4i2.9165
562. Preziosi, T. J., Starkstein, S. E., Bolduc, P. L., & ROBINSON, R. G. (1990). Depression in Parkinson??s Disease. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/00005053-199001000-00005
563. Prvčić, I., Zec, M. R., & Barišić, I. (2008). Psychological aspects of learning disabilities. Paediatria Croatica. https://doi.org/10.13112/pc.925
564. Putra, H. G. S. A. (2015). GANGGUAN AFEKTIF BIPOLAR MANIA DENGAN PSIKOTIK: SEBUAH LAPORAN KASUS. DOAJ (DOAJ: Directory of Open Access Journals).
565. Pérez, P. S. (2015). El déficit cognitivo en el síndrome de fatiga crónica: factores asociados y evolución.
566. Pérez, Á. M. S., Granados, F. J. V., Salazar, M. H., Méndez, A. Z., & Dávalos, É. M. (2005). Síndrome prefrontal ventromedial. Reporte de caso. Neurología, Neurocirugía y Psiquiatría.
567. Pérez-Romero, J. L., Hernández‐Fernández, F., Moratalla, A. B. P., Ayo‐Martín, Ó., & Rubio, M. E. O. (2010). Síncopes de Repetición como presentación de Encefalopatía de Wernicke-Korsakov. Revista Clínica de Medicina de Familia. https://doi.org/10.4321/s1699-695x2010000200017
568. Rabe‐Jabłońska, J. (1998). [Results of long-term observation (3-11 years) of patients with dual diagnosis: body dysmorphic disorder and delusional disorder, somatic type].. PubMed.
569. Rabia, K., & Khoo, E. M. (2008). A mentally retarded patient with schizophrenia.. DOAJ (DOAJ: Directory of Open Access Journals).
570. Rachmani, S., & Mayasari, D. (2017). Kombinasi Farmakoterapi dan Psikoterapi Pada Pengobatan Episode Depresif Sedang Dengan Gejala Somatis. Jurnal Medula.
571. Rades, M., & Wulandari, A. J. (2016). Skizoafektif Tipe Campuran. Jurnal Medula.
572. Radmanović, M. B. (2012). First-psychotic episode in childhood and adolescence.. PubMed.
573. Radmanović, M. B., & Burgić, S.-S. (2020). Comorbidity in Children and Adolescents with ADHD. IntechOpen eBooks. https://doi.org/10.5772/intechopen.94527
574. Raj, S., & Gale, S. A. (2017). [P4–173]: NEW ONSET PSYCHOTIC SYMPTOMS AS THE INITIAL PRESENTATION OF EARLY ONSET ALZHEIMER'S DISEASE. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2017.06.2040
575. Raja, S., Kotturu, M. K., Kandriga, V. K. R., & Potla, V. K. (2022). A rare case of early onset childhood schizophrenia with predominant negative symptoms. International Journal of Contemporary Pediatrics. https://doi.org/10.18203/2349-3291.ijcp20221082
576. Raju, V. R. (2023). Awareness of medical issues in health sciences and in scientific technological education. IP Journal of Nutrition Metabolism and Health Science. https://doi.org/10.18231/j.ijnmhs.2023.018
577. Ramos, M. F., Uribe, M. O., & Sotres, J. C. (2003). Comparación entre el tratamiento continuo y el intermitente con citalopram para el trastorno disfórico premenstrual. Salud Mental.
578. Ranganathan, A., & Beitman, B. D. (1998). Panic disorder: a different perspective.. PubMed.
579. Rani, M. K. S., Fathima, S. T., Gayathri, S. L., Pavani, M., & Swathi, Y. (2022). Detection of Autism Spectrum Disorder using Machine Learning. International Journal of Advanced Research in Science Communication and Technology. https://doi.org/10.48175/ijarsct-7600
580. Rascol, O., Payoux, P., Ory, F., Ferreira, J. J., Brefel‐Courbon, C., & Montastruc, J. (2003). Limitations of current Parkinson's disease therapy. Annals of Neurology. https://doi.org/10.1002/ana.10513
581. Ray, C., Jeffefues, S., Weir, W., Hayes, K., Simon, S., Akingbade, F., & Marriott, P. (1998). Making sense of chronic fatigue syndrome: Patients' accounts of onset. Psychology and Health. https://doi.org/10.1080/08870449808406134
582. Rayfield, A., Thomas, C., & Borovicka, M. C. (2014). Management of behavioral and psychological symptoms of dementia: The role of mood stabilizers. Mental Health Clinician. https://doi.org/10.9740/mhc.n204493
583. Reddy, M. S. (2014). Irritability as a Criterion in Diagnosis of Child and Adolescent Bipolar Disorder: Thorny Road Ahead. Indian Journal of Psychological Medicine. https://doi.org/10.4103/0253-7176.130954
584. Reid, W. H., Balis, G. U., & Sutton, B. (1997). The treatment of psychiatric disorders : revised for DSM-IV.
585. Reilly, C., Senior, J., & Murtagh, L. (2014). <scp>ASD</scp>, <scp>ADHD</scp>, mental health conditions and psychopharmacology in neurogenetic syndromes: parent survey. Journal of Intellectual Disability Research. https://doi.org/10.1111/jir.12147
586. Reinares, M., Martínez‐Arán, A., & Vieta, E. (2019). Psychoeducation for Patients and Family Members. Cambridge University Press eBooks. https://doi.org/10.1017/9781108589802.004
587. Remschmidt, H. (2008). Schizophrenia in Children and Adolescents. KARGER eBooks. https://doi.org/10.1159/000118520
588. Rhouma, H. B., Kraoua, I., Yacoubi, J., Fradj, N., & Gouider‐Khouja, N. (2012). Psychogenic Dystonia in Tunisian Children. Journal of Behavioral and Brain Science. https://doi.org/10.4236/jbbs.2012.22023
589. Rico, B. (2012). Finding a druggable target for schizophrenia. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1209389109
590. Robinson, E., Neale, B. M., & Daly, M. J. (2017). Diagnosis and Epidemiology of Pediatric Psychiatric Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190681425.003.0058
591. Rodrigo, M. V. L., Oliver, A. O., Monge, M. P., Fons, V. R., & Cantalejo, Y. D. (2023). Stigma of mental illness in the gypsy ethnic group. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.1438
592. Rodríguez, E. O., Esquivel, P. S., & Triana, I. M. (2024). Un panorama actualizado de la dispepsia. Revista médica de Panamá. https://doi.org/10.37980/im.journal.rmdp.20242296
593. Rodríguez, M. R., Nuevo, R., Chatterji, S., & Ayuso‐Mateos, J. L. (2012). Definitions and factors associated with subthreshold depressive conditions: a systematic review. BMC Psychiatry. https://doi.org/10.1186/1471-244x-12-181
594. Roecklin, K. A., & Rohan, K. J. (2010). Seasonal Affective Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0830
595. Rogers, N. L., & Kloss, J. D. (2004). Medical Conditions and Diseases. CRC Press eBooks. https://doi.org/10.3109/9780203998007-6
596. Rohde, P., Lewinsohn, P. M., & Seeley, J. R. (1991). Comorbidity of unipolar depression: II. Comorbidity with other mental disorders in adolescents and adults.. Journal of Abnormal Psychology. https://doi.org/10.1037/0021-843x.100.2.214
597. Rollas, E. (2021). A Short Note on the Assessment and Treatment of Behavioral and Psychological Health in Older patients. Journal of Multiple Sclerosis. https://doi.org/10.35248/2376-0389.21.8.256
598. Rollas, E. (2021). Assessment and Treatment of Behavioral and Psychological Health in Older. Clinical and Experimental Psychology. https://doi.org/10.35248/2471-2701.21.7.238
599. Roncero, C., & Casas, M. (2004). Trastornos de ansiedad en patología dual.
600. Rosenblatt, A. (2007). Understanding the psychiatric prodrome of Huntington disease. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2006.112565
601. Rozenfeld, I., & Duarte, E. M. (2014). Poster Session : PS 0614 ; Others ; Common Variable Immune Defi ciency in a Patient with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Non-Specifi c Oral Ulcers. 대한내과학회 추계학술발표논문집.
602. Rozhkova, N. Y., & Rozhkova, M. Y. (2014). Prodrome of Paranoid Schizophrenia with Episodic Type of Course and Schizoaffective Structure of Manifest Episode. DOAJ (DOAJ: Directory of Open Access Journals).
603. Rucci, J. M., & Feinstein, R. E. (2014). Neurocognitive Disorders and Mental Disorders Due to Another Medical Condition. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199326075.003.0005
604. Rudolf, G. A. E. (2000). Diagnostische und therapeutische Maßnahmen bei einzelnen schizophrenen Syndromen und in bestimmten krankheitsbedingten Situationen. Deutscher Universitätsverlag eBooks. https://doi.org/10.1007/978-3-322-85177-2_7
605. Ruiz-Padrino, N., & Andrés-Tauler, J. M. (2014). Episodio hipomaniaco secundario al tratamiento con claritromicina en paciente adolescente. Revista de Psiquiatría Infanto-Juvenil.
606. Ruttley, A., Ng, A., & Burnside, A. M. (2014). Medically Unexplained Symptoms and Health Anxieties: Somatic Symptom and Related Disorders. https://doi.org/10.1002/9781118560648.ch18
607. Ružić, M. (2016). Poremećaj glasa kod osoba treće životne dobi.
608. Saad, M. A. E., & Kamel, O. M. (2019). Childhood-Onset Fluency Disorder (Stuttering): An Interruption in The Flow of Speaking. International Journal of Psycho-Educational Sciences.
609. Sadek, J. (2023). Attention Deficit Hyperactivity Disorder Misdiagnosis: Why Medical Evaluation Should Be a Part of ADHD Assessment. Brain Sciences. https://doi.org/10.3390/brainsci13111522
610. Sakakibara, R., & Katsuragawa, S. (2023). Depression and LUT (Psychogenic LUTS). https://doi.org/10.1007/978-981-99-1659-7_78
611. Salokangas, R. K. R., & McGlashan, T. H. (2008). Early detection and intervention of psychosis. A review. Nordic Journal of Psychiatry. https://doi.org/10.1080/08039480801984008
612. Samsonov, I. S., Kopeyko, G. I., Gedevani, E., & Kaleda, V. G. (2021). The varieties of delusional syndrome of possession in schizophrenia. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.2040
613. San, L., Herrero, R. M. D., & Martí, B. A. (2004). Aspectos generales de la patología dual.
614. San, L., Martı́nez-Raga, J., Martí, B. A., & Serecigni, J. G. (2004). Otros diagnósticos en patología dual.
615. Sansone, R. A., & Sansone, L. A. (2010). Medically Unexplainable Somatic Symptoms: A Coat With Many Psychiatric Colors. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.09l00879gre
616. Santillán-López, L. G., & Medrano-Freire, E. L. (2021). Importancia de la pedagogía en los estudiantes con TADH. Aspectos relevantes. Polo del Conocimiento. https://doi.org/10.23857/pc.v6i7.2876
617. Santos, M. G. (2023). Adult ADHD: 6 studies of pharmacologic interventions. Current psychiatry. https://doi.org/10.12788/cp.0344
618. Saparudin, I. F., Sham, F. M., & Hamjah, S. H. (2014). [ms] Hysterical Symptom among School Youth in Malaysia. Islāmiyyāt.
619. Saparudin, I. F., Sham, F. M., & Hamjah, S. H. (2014). Simptom Histeria dalam Kalangan Remaja Sekolah di Malaysia. Islamiyyat. https://doi.org/10.17576/islamiyyat-2014-3602-03
620. Saputra, A. D., Saraswati, D., Saputri, M. E., Indriani, N., & Arini, L. D. D. (2024). Gangguan Skizofrenia Pada Remaja di Indonesia. Jurnal Kajian dan Penelitian Umum. https://doi.org/10.47861/jkpu-nalanda.v2i3.1012
621. Sardiani, S. (2023). Aplikasi Asuhan Keperawatan Jiwa Pada Tn. A Dengan Gangguan Persepsi Sensori:Halusinasi Pendengaran Diruangan Dolok Sanggul II. https://doi.org/10.31219/osf.io/kyqd2
622. Sari, M. N., Sulyaman, S., Sulistiono, A., & Ramadhian, M. R. (2016). Gangguan Kepribadian dan Perilaku Akibat Penyakit, Kerusakan, dan Disfungsi Otak pada Pria Usia 45 Tahun. Jurnal Medula.
623. Sarkar, S. (2016). Psychiatric Polypharmacy, Etiology and Potential Consequences. Current Psychopharmacologye. https://doi.org/10.2174/2211556005666160916124719
624. Sarkar, S., & Dinesh, M. (2023). The threshold problem of impairment criteria in psychiatric diagnosis. Journal of SAARC Psychiatric Federation. https://doi.org/10.4103/jspf.jspf_12_23
625. Sarõ, A. (2005). Of Illusions, Hallucinations and Creutzfeldt-Jakob Disease (Heidenhain's Variant).
626. Sass, L. A. (2003). “Negative Symptoms,” Commonsense, and Cultural Disembedding in the Modern Age. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511616297.015
627. Saxena, C. (2022). A Case Report on Generalized Anxiety Disorder through Medical Cannabis. Journal of Case Reports and Scientific Images. https://doi.org/10.22271/27080056.2022.v4.i1a.45
628. Sazonov, S. (2014). EPA-0651 – The complexity of psychopathological symptom as a possible indication of mental disease's etiology. European Psychiatry. https://doi.org/10.1016/s0924-9338(14)78023-x
629. Scarabino, D., Mantuano, E., & Peconi, M. (2019). Can leukocyte telomere shortening be a possible biomarker to track Huntington’s disease progression?. Neural Regeneration Research. https://doi.org/10.4103/1673-5374.257522
630. Schenck, C. H. (2003). Assessment and Management of Insomnia. JAMA. https://doi.org/10.1001/jama.289.19.2475
631. Scherbaum, N., & Specka, M. (2014). Komorbide psychische Störungen bei Opiatabhängigen. Suchttherapie. https://doi.org/10.1055/s-0033-1363240
632. Schneier, F. R., Bruce, L. C., & Heimberg, R. G. (2014). Social Anxiety Disorder (Social Phobia). American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg18
633. Schulkens, J. E. M., Ibirane, J., Alphen, S. V., & Sobczak, S. (2019). Farmacotherapie bij ouderen met persoonlijkheidsstoornissen: een nieuw aandachtsgebied. Tijdschrift voor Gerontologie en Geriatrie. https://doi.org/10.36613/tgg.1875-6832/2019.03.01
634. Schultze‐Lutter, F. (2016). First Signs of Emerging Psychosis. Key issues in mental health (Online)/Key issues in mental health (Print). https://doi.org/10.1159/000440912
635. Schulze‐Bonhage, A., Oehl, B., Wagner, K., Velthofen, V. V., & Trippel, M. (2008). Course, characteristics, and therapeutic options in gelastic epilepsy. Neuropediatrics. https://doi.org/10.1055/s-2008-1079484
636. Scott, R. C., Surtees, R., & Neville, B. (1998). Status epilepticus: pathophysiology, epidemiology, and outcomes. Archives of Disease in Childhood. https://doi.org/10.1136/adc.79.1.73
637. Seidenberg, M., & Hermann, B. P. (2010). A lifespan perspective of cognition in epilepsy. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511674815.029
638. Seifert, B., Lukáš, K., Charvátová, E., Vojtíšková, J., Koudelka, T., Hep, A., Bureš, J., Jirásek, V., & Dítě, P. (2007). Lower dyspeptic syndrome. Recommended diagnostic and therapeutic procedures for general practitioners 2006.
639. Seifert, K. (2014). Aversive Childhood Experiences, Without Appropriate Interventions, Lead to Life Course Violent and Criminal Behavior. Journal of Psychology & Clinical Psychiatry. https://doi.org/10.15406/jpcpy.2014.01.00020
640. Seligman, L. D., Swedish, E. F., & Ollendick, T. H. (2014). Anxiety Disorders in Children. https://doi.org/10.1002/9781394259359.ch7
641. Selwood, L. (2015). Adherence in schizophrenia. Mental Health Matters.
642. Sharabyani, S. M. (2016). MENTAL DISORDER AND THEIR TREATMENT. Journal of Fundamental and Applied Sciences. https://doi.org/10.4314/jfas.v8i3s.388
643. Sharma, S., Kishore, J., & Gupta, V. (2014). Adolescent Mental Health: From Normalcy to Illness. Indian Journal of Youth and Adolescent Health.
644. Shea, Y. F., Ha, J., & Chu, L. (2014). Progressive Supranuclear Palsy Presenting Initially As Semantic Dementia. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.13145
645. Sheets, E. S., & Brosse, A. L. (2010). Major Depressive Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0522
646. Sher, L. (2003). Aetiology and pathogenesis of mood disorders. QJM. https://doi.org/10.1093/qjmed/hcg044
647. Sher, L. (2015). Parental alienation: the impact on men’s mental health. International Journal of Adolescent Medicine and Health. https://doi.org/10.1515/ijamh-2015-0083
648. Sherry, A. (2010). Borderline Personality Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0136
649. Shih, T., & Bazil, C. W. (2005). Treatment of Generalized Convulsive Status Epilepticus. Humana Press eBooks. https://doi.org/10.1385/1-59259-945-1:265
650. Shorvon, S. (1987). Intensive Neurodiagnostic Monitoring. (Advances in Neurology Vol 46).. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.50.9.1247-a
651. Siddiqui, J. A., Qureshi, S. F., & Ghamdi, A. K. A. (2017). Alien Abductions: A Case of Sleep Paralysis. Sleep and Hypnosis. https://doi.org/10.5350/sleep.hypn.2017.19.0144
652. Sievers, M., Sato, T., Möller, H.-J., & Bottlender, R. (2005). Obsessive-compulsive Disorder (OCD) with Psychotic Symptoms and Response to Treatment with SSRI. Pharmacopsychiatry. https://doi.org/10.1055/s-2005-837814
653. Silva, J. B. M. D., Cerqueira, R. B. D. O., Pereira, C. A. L. V., Rodrigues, R. K. C., Tenório, G. D. A., Silva, E. N. D., Fachin, L. P., & Padilha, J. F. D. M. S. (2023). Diagnóstico errôneo de esquizofrenia em paciente bipolar: um relato de caso. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv6n4-005
654. Silva, L. I. F. D., Souza, L. M., Gonzales, M. F., & Jurado, S. R. (2015). SLEEP DISORDERS IN CHILDHOOD. Simpósio Internacional de Neurociências da Grande Dourados.
655. Silver, R. M., & Airoldi, J. (2016). 27. Inherited thrombophilia. CRC Press eBooks. https://doi.org/10.1201/9781315200910-28
656. Singh, B., Hooda, P., Sabah, C., & Srivastava, M. K. (2022). Free Papers Compiled. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.341600
657. Singh, R. K., Chauhan, V. S., Panda, S. P., Prakash, J., & Chatterjee, K. (2023). Preeclamptic psychosis. Industrial Psychiatry Journal. https://doi.org/10.4103/ipj.ipj_246_23
658. Singh, S. (2015). Mental health in infancy. International Journal of Clinical & Medical Imaging. https://doi.org/10.4172/2376-0249.1000393
659. Sinha, S., Moss, A. J., & Calkins, H. (2007). The etiology of sudden death. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544828.014
660. Skelton, N. K., & Cornette, M. (2009). [Parkinson's disease here and now, a study of 50 cases]..
661. Skjelstad, D. V., Holte, A., & Malt, U. F. (2012). Putative early manifestations of bipolar II disorder emerge later in the initial prodrome than manifestations hypothesized to be unrelated: an exploratory study. Early Intervention in Psychiatry. https://doi.org/10.1111/j.1751-7893.2012.00348.x
662. Skoczeń, N., Masternak, S., & Olajossy, M. (2016). Extraordinary system of delusions and the social functioning - a case study. Current Problems of Psychiatry. https://doi.org/10.1515/cpp-2016-0003
663. Skokauskas, N., Pillay, D., Moran, T., & Kahn, D. (2010). Transient Auditory Hallucinations in an Adolescent. Journal of Psychiatric Practice. https://doi.org/10.1097/01.pra.0000375716.77831.ca
664. Small, G. W. (1984). Psychiatric Problems Affecting Dental Care of the Elderly<sup>1</sup>. Gerodontology. https://doi.org/10.1111/j.1741-2358.1984.tb00046.x
665. Smith, P. J., & Blumenthal, J. A. (2015). Exercise and Physical Activity in the Prevention and Treatment of Depression. Routledge eBooks. https://doi.org/10.4324/9780203132678.ch8
666. Soares, W. B., & Lima, A. M. D. O. (2024). First Episode of Psychosis. Advances in medical technologies and clinical practice book series. https://doi.org/10.4018/979-8-3693-0851-6.ch005
667. Socia, S. (1998). REPORT OF TWO CASES WITH EEGs.
668. Soe, K. C., & Lopez, W. L. (2022). Clinical progress note: Management of somatic symptom and related disorders in pediatric inpatients. Journal of Hospital Medicine. https://doi.org/10.1002/jhm.12947
669. Sommer, I. E., & Arango, C. (2017). Moving interventions from after to before diagnosis. World Psychiatry. https://doi.org/10.1002/wps.20454
670. Sommer, I. E., & Spek, D. W. V. D. (2016). [Hearing voices does not always constitute a psychosis].. PubMed.
671. Sonino, N., & Fava, G. A. (1998). Psychosomatic Aspects of Cushing’s Disease. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000012274
672. Sood, M., & Kattimani, S. (2008). Childhood Onset Schizophrenia: Clinical Features, Course and Outcome. Journal of Indian Association for Child and Adolescent Mental Health. https://doi.org/10.1177/0973134220080202
673. Sophia, M. (2009). A Study on Psychopathology and Quality of Life in Children with Leukemia and their Parents..
674. Soysal, P., & Işık, A. T. (2014). Hypoactive Delirium Caused by Pulmonary Embolus in an Elderly Adult. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.12720
675. Stein, D. J., Blumenshon, R., Hanukoglu, A., & Witztum, E. (2003). [Cyclic psychosis associated with the menstrual cycle].. PubMed.
676. Steinberg, D. (1987). Basic adolescent psychiatry.
677. Steinberg, J. (1981). Depression and abnormal endocrinologic tests. JAMA. https://doi.org/10.1001/jama.246.18.2032
678. Stone, J., Carson, A., & Sharpe, M. (2005). Functional symptoms in neurology: management. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2004.061663
679. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
680. Stone, W. S., Faraone, S. V., & Tsuang, M. T. (2020). Schizoaffective and schizotypal disorders/acute and transient psychotic disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198713005.003.0061
681. Strain, J. J., Klipstein, K., & Newcorn, J. H. (2008). Adjustment Disorders. Psychiatry. https://doi.org/10.1002/9780470515167.ch81
682. Stringaris, A., & Krieger, F. (2013). Bipolar disorder and disruptive mood dysregulation in children and adolescents: assessment, diagnosis and treatment. Evidence-Based Mental Health. https://doi.org/10.1136/eb-2013-101400
683. Stringer, S., Nieman, D. H., Kahn, R. S., & Derks, E. M. (2015). Genome-wide association analysis in schizophrenia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781107337459.010
684. Stubbe, D. (2007). Child and adolescent psychiatry : a practical guide. Lippincott Williams & Wilkins eBooks.
685. Stumpf, B. P., & Rocha, F. L. (2010). Síndrome de Diógenes. Jornal Brasileiro de Psiquiatria. https://doi.org/10.1590/s0047-20852010000200012
686. Suarte, L. A. M., Oliveira, R. F. L. D., Maia, D. C., Schneiberg, S., & Santana, L. S. (2014). Tratamento fisioterapêutico na criança hipotônica. Semana de Pesquisa e Extensão da Universidade Tiradentes - SEMPESq-SEMEX.
687. Sung, H. C., & Chang, A. B. (2010). The effectiveness of preferred or familiar music listening on behavioural and psychological symptoms of institutionalised older adults with dementia: a systematic review. JBI Library of Systematic Reviews. https://doi.org/10.11124/jbisrir-2010-726
688. Sung, H. C., & Chang, A. B. (2010). The effectiveness of preferred or familiar music listening on behavioural and psychological symptoms of institutionalised older adults with dementia: a systematic review. The JBI Database of Systematic Reviews and Implementation Reports. https://doi.org/10.11124/01938924-201008341-00020
689. Suzuki, K., Fujita, H., Watanabe, Y., Matsubara, T., Kadowaki, T., Sakuramoto, H., Hamaguchi, M., Nozawa, N., & Hirata, K. (2019). Leg restlessness preceding the onset of motor symptoms of Parkinson disease. Medicine. https://doi.org/10.1097/md.0000000000016892
690. Swann, A. C. (2009). Pharmacologic Mood Destabilization: <i>Case Vignettes</i>. CNS Spectrums. https://doi.org/10.1017/s1092852900003898
691. Sweet, G., Kim, S., Martin, S. A., Washington, N. B., & Brahm, N. C. (2017). Psychiatric symptoms and synthetic cannabinoid use: Information for clinicians. Mental Health Clinician. https://doi.org/10.9740/mhc.2017.07.156
692. Szaffarczyk, S., Lapierre, P., Danel, T., Cottencin, O., & Pins, D. (2015). Étude du sentiment de familiarité dans l’alcoolo-dépendance : une hyperfamiliarité aux visages. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2015.09.199
693. Szkodny, L. E., Jacobson, N. C., Llera, S. J., & Newman, M. G. (2014). Generalized Anxiety Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg19
694. Szuhany, K. L., & Simon, N. M. (2022). Anxiety Disorders. JAMA. https://doi.org/10.1001/jama.2022.22744
695. Szymanowska, J. (2025). Rola psychoterapii poznawczo-behawioralnej w procesie leczenia zaburzeń depresyjnych u osób starszych. Kultura i Edukacja. https://doi.org/10.15804/kie.2025.01.10
696. Sánchez, L. C., Cardona, A., cordoba, S., Silva, A. V., Ruiz, A. C., Ibáñez‐Pinilla, M., Pérez-Olmos, I., & Flórez, J. (2010). Experiencias de estigma en personas con enfermedad mental y su impacto en la autoestima en Colombia. reponame:Repositorio Institucional EdocUR.
697. Tabaasum, N., & Islam, F. (2022). Schizoid personality disorder: a rare type. Bangladesh Journal of Psychiatry. https://doi.org/10.3329/bjpsy.v36i2.72753
698. Tabbane, K., Triki, R., Hajeri, S., Johnson, I., & Chérif, W. (2012). P-1319 - Prodromal symptoms of schizophrenia: a retrospective tunisian study. European Psychiatry. https://doi.org/10.1016/s0924-9338(12)75486-x
699. Takaishi, Y., Hashimoto, K., & Enokido, H. (1991). A study of idiopathic epilepsy of childhood with occiptal electroencephalographic foci.. Journal of Nippon Medical School. https://doi.org/10.1272/jnms1923.58.686
700. Tamam, L. (2015). Impulse control disorders: DSM-5 and beyond. Anatolian Journal of Psychiatry.
701. Tamminga, C. A., Buchanan, R. W., & Gold, J. M. (1998). The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199803003-00004
702. Tang‐Wai, D. F., Josephs, K. A., & Petersen, R. C. (2005). Alzheimer's disease: overview. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544873.029
703. Tatsuzawa, Y., Ono, Y., Takahashi, T., Yoshino, A., & Nomura, S. (2011). Case of isolated adrenocorticotropic hormone deficiency mimicking major depressive disorder. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.2011.02207.x
704. Tatulian, S. E., Vasiliev, S. V., Yavorskaya, V. V., & Zheltyakova, Z. A. (2005). The Influence of Somatoneurological Decompensations in the Course of Old-Age Depressive Disorders. International Journal of Mental Health. https://doi.org/10.2753/imh0020-7411340410
705. Taylor, M. A. (1999). Personality And Personality Disorders. https://doi.org/10.1093/oso/9780195130379.003.0006
706. Taylor, M. E., & Whitney, J. (2021). Impaired Cognition and Falls. Cambridge University Press eBooks. https://doi.org/10.1017/9781108594455.009
707. Taylor, R., Smith, B. H., & Teijlingen, E. V. (2003). Chronic illness. https://doi.org/10.1093/oso/9780192631688.003.0015
708. Telbizova, T., Aleksandrov, I., & Arnaoudova, M. (2020). DYNAMICS OF PSYCHIATRIC SYMPTOMS IN CUSHING’S SYNDROME. Journal of IMAB - Annual Proceeding (Scientific Papers). https://doi.org/10.5272/jimab.2020264.3443
709. Terçariolli, B. I., Rosa, J. M., Vieira, G. P., Cardoso, R., & Lage, P. S. (2024). RESUMO Introdução: Os transtornos mentais são definidos como sendo síndromes caracterizadas por uma perturbação clinicamente expressiva na cognição, na regulação emocional ou no comportamento de um indivíduo, que refletem uma disfunção nos processos psicológicos, biológicos ou de desenvolvimento subjacentes ao funcionamento mental. Estes estão frequentemente associados ao sofrimento ou às incapacidades. Sabe-se que uma das características marcantes de determinados transtornos está relacionada à…. Revista fisio&terapia.. https://doi.org/10.69849/revistaft/fa1020240911111905
710. Thomas, P., Beaumanoir, A., Genton, P., Dolisi, C., & Chatel, M. (1992). 'De novo' absence status of late onset. Neurology. https://doi.org/10.1212/wnl.42.1.104
711. Thompson, W., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller‐Lissner, S. (1999). Functional bowel disorders and functional abdominal pain. Gut. https://doi.org/10.1136/gut.45.2008.ii43
712. Thomsen, T., & Miyasaki, J. M. (2012). Psychogenic Movement Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-120-2_7
713. Tiffon, B.-N. (2022). Borderline Personality Disorder. CRC Press eBooks. https://doi.org/10.4324/9781003092223-8
714. Tikhonravova, D. V. (2023). All you need to know about sarcopenia: a short guide for an internal medicine physician in questions and answers. Bulletin of Siberian Medicine. https://doi.org/10.20538/1682-0363-2023-3-88-97
715. Tiryaki, A., Özkorumak, E., & Ak, İ. (2009). Deficit syndrome in schizophrenia. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology.
716. Tito, E., Knapp, B., Bucca, A., & Espiridion, E. D. (2019). A Case Report of Schizoaffective Disorder with Pseudoseizures in a 42-year-old Male. Cureus. https://doi.org/10.7759/cureus.4835
717. Tobia, A. (2016). A Dental Crown for Patients with Schizophrena. Journal of Dentistry and Oral Care. https://doi.org/10.15436/2379-1705.16.919
718. Tobin, D. L., Molteni, A., & Elin, M. R. (1995). Early trauma, dissociation, and late onset in the eating disorders. International Journal of Eating Disorders. https://doi.org/10.1002/1098-108x(199504)17:3<305::aid-eat2260170312>3.0.co;2-f
719. Todorović, S. (2016). Socijalno medicinske karakteristike i razlike između alkoholičara sa periodičnim i kontinuiranim pijenjem / Social and Medical Characteristics and Differences Between Alcoholics With Periodic and Continuous Drinking. SESTRINSKI ŽURNAL. https://doi.org/10.7251/sez0116005t
720. Tomasetti, C. (2014). Spatial and temporal patterns of postsynaptic genes and proteins expression by multiple receptors targeting agents: unraveling the impact of multitargeting approach on dopamine-glutamate mediated synaptic plasticity.
721. Tomaz, B. C. A., Costallat, G. L., & Henna, E. (2017). Prolonged Hypomanic, Five Years Running Wild: Case Report. SM Journal of Depression Research and Treatment. https://doi.org/10.36876/smjdrt.1014
722. Tondo, L., Albert, M. J., Koukopoulos, A. E., Baethge, C., & Baldessarini, R. J. (2005). Bipolar Disorder. Humana Press eBooks. https://doi.org/10.1385/1-59259-856-0:205
723. Townsend, M. C. (2004). Nursing diagnoses in psychiatric nursing : care plans and psychotropic medications. F.A. Davis Co. eBooks.
724. Tran, K., & Ford, C. (2020). Lurasidone Hydrochloride for Bipolar Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines [Internet].
725. Trisnawati, S. Y., Gde, P. S. D. P., Kurniawan, L. S., Goller, A. A. C., & Dewi, V. T. (2022). GEJALA PSIKOTIK PADA PENYAKIT PARKINSON: SEBUAH LAPORAN KASUS DAN TINJAUAN PUSTAKA. Callosum Neurology. https://doi.org/10.29342/cnj.v4i2.152
726. Tseng, W.-S. (2012). Culture-related specific psychiatric syndromes. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0125
727. Tso, I. F., Chun, J., & Deldin, P. J. (2010). Schizoaffective Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0818
728. Tungpunkom, P., Srikhachin, P., Napa, W., & Chaniang, S. (2012). Caregiving Experiences of Families Living with Patients with Schizophrenia: a Systematic Review.. JBI Library of Systematic Reviews. https://doi.org/10.11124/jbisrir-2012-324
729. Tölle, R., & Goetze, U. (1981). [Antidepressive effect of partial sleep deprivation during the 1st half of the night].. PubMed.
730. Ugarte, K., Arroita, A., Barreiro, A., Losada, N. G., Rico, P., Touzon, R., & Lopez, M. (2009). Psychiatric Comorbidity in Fibromyalgia. European Psychiatry. https://doi.org/10.1016/s0924-9338(09)70842-9
731. Uppal, T., Amarasekara, C., & Kaushik, V. (2011). Chronic pelvic pain. Australasian Journal of Ultrasound in Medicine. https://doi.org/10.1002/j.2205-0140.2011.tb00182.x
732. Usón, J. R. V., & Gracia, A. C. I. (2009). Trastorno por déficit de atención/hiperactividad en adultos. Revista de Neurología. https://doi.org/10.33588/rn.48s02.2009017
733. Valdizán, J. R., & Izaguerri-Gracia, A. C. (2005). Attention Deficit/Hyperactivity Disorder in Adults. Encyclopedia of Applied Developmental Science. https://doi.org/10.4135/9781412950565.n52
734. Vale, T. C., Pedroso, J. L., Knobel, M., & Knobel, E. (2016). Late-Onset Psychogenic Chronic Phonic-Tics. Tremor and Other Hyperkinetic Movements. https://doi.org/10.5334/tohm.299
735. Vallejo, J. D. O. (2001). Detecció precoç de la depressió. Revista de la Reial Acadèmia de Medicina de Catalunya.
736. Vallée, J.-P. (2010). Énurésie nocturne : informer/conseiller, évaluer, traiter. Médecine.
737. Vamsi, M., Prasad, K. S., Rajendhar, S., & Raviteja, I. (2022). Abstract- Poster. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.341972
738. Vanin, J. R. (2008). Brief Psychiatric History and Mental Status Examination. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-263-2_2
739. VANVALKENBURG, C., Lilienfeld, S. O., & Akiskal, H. S. (1987). The impact of familial personality disorder and alcoholism on the clinical features of depression. Psychiatry and Psychobiology. https://doi.org/10.1017/s0767399x00004284
740. Varghese, R., John, D., & Arun, M. (2007). A case of primary hypersomnia. Annals of Indian Academy of Neurology. https://doi.org/10.4103/0972-2327.31489
741. Vicente, J. F. M. (2014). Estado epiléptico refractario en el entorno de la terapia intensiva. Medicina Crítica.
742. Vijay, P., Aziz, S., & Chaudhury, S. (2023). A Rare Case of Very Young-Onset Dementia Presenting as Conversion Disorder. Medical Journal of Dr D Y Patil Vidyapeeth. https://doi.org/10.4103/mjdrdypu.mjdrdypu_174_23
743. Viola, L. (2011). [The severe dysregulated child. Clinical research].. PubMed.
744. Vitiello, B., Zuddas, A., & Masi, G. (2006). Pharmacologic treatment of children and adolescents with attention deficit hyperactivity disorder. CRC Press eBooks. https://doi.org/10.1201/b14454-11
745. Vogel, J. M., & Vernberg, E. M. (1993). Part 1: Children's Psychological Responses to Disasters. Journal of Clinical Child Psychology. https://doi.org/10.1207/s15374424jccp2204_7
746. Volel, B. A., & Ian'shina, T. P. (2005). Involutional hysteria as a form in dynamics of personality disorder.
747. Volpe, F. M., & Tavares, A. (2000). Cyproterone for Hypersexuality in a Psychotic Patient with Wilson's Disease. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1080/j.1440-1614.2000.0822l.x
748. Vonk, R. (2016). The influence of genes and environment on the development of bipolar disorder: A twin study.
749. Voon, V., Thomsen, T., Miyasaki, J. M., Souza, M. D., Shafro, A., Fox, S. H., Duff‐Canning, S., Lang, A. E., & Zurowski, M. (2007). Factors Associated With Dopaminergic Drug–Related Pathological Gambling in Parkinson Disease. Archives of Neurology. https://doi.org/10.1001/archneur.64.2.212
750. Waite, J., Harwood, R., Morton, I., & Connelly, D. (2008). Rarer causes of dementia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199228829.003.0015
751. Wakil, L., Meltzer‐Brody, S., & Girdler, S. S. (2012). Premenstrual Dysphoric Disorder: How to Alleviate Her Suffering; Accurate Diagnosis, Tailored Treatments Can Greatly Improve Women's Quality of Life. Current psychiatry.
752. Walder, D. J., Statucka, M., Daly, M., & Yaffe, B. (2014). Psychotic Disorders. Psychology. https://doi.org/10.1093/obo/9780199828340-0151
753. Walker, E. F. (1981). Attentional and Neuromotor Functions of Schizophrenics, Schizoaffectives, and Patients With Other Affective Disorders. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1981.01780370057006
754. Wallace, S. J. (2015). Epilepsy in children. Chapman & Hall Medical eBooks.
755. Walther, M., & Woods, D. W. (2010). Trichotillomania. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy1011
756. Ward, B. K., Berg, R. V. D., Rompaey, V. V., Bisdorff, A., Hullar, T. E., Welgampola, M. S., & Carey, J. P. (2021). Superior semicircular canal dehiscence syndrome: Diagnostic criteria consensus document of the committee for the classification of vestibular disorders of the Bárány Society. Journal of Vestibular Research. https://doi.org/10.3233/ves-200004
757. Weisholtz, D. S., & Dworetzky, B. A. (2014). Epilepsy and Psychosis.
758. Weller, E. B., Weller, R. A., & Dogin, J. W. (1998). A rose is a rose is a rose. Journal of Affective Disorders. https://doi.org/10.1016/s0165-0327(98)00180-3
759. Werf, C. V. D., Langen, I. M. V., & Wilde, A. A. (2010). Sudden Death in the Young. Circulation Arrhythmia and Electrophysiology. https://doi.org/10.1161/circep.109.877142
760. Wertheimer, J. (2001). Psychiatric Treatment and Rehabilitation of the Elderly Mentally Ill. Contemporary psychiatry. https://doi.org/10.1007/978-3-642-59519-6_53
761. Wichaidit, B. T., Rask, C. U., & Østergaard, J. R. (2014). [Diagnosing functional seizures in children and adolescents].. Research Portal Denmark.
762. Widiger, T. A. (1994). DSM-IV sourcebook. American Psychiatric Association eBooks.
763. Wieck, A. (2021). Risk of severe postpartum episodes. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.202
764. Willner, P. (1984). Drugs, Biochemistry, and Conscious Experience: Toward a Theory of Psychopharmacology. Perspectives in biology and medicine. https://doi.org/10.1353/pbm.1984.0009
765. Winner, P., Hershey, A. D., & Li, Z. (2007). Headaches in Children. https://doi.org/10.1093/oso/9780195326567.003.0027
766. Winters, K. C., & Ingwalson, A. (2022). Internalizing and Related Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190678487.003.0006
767. Wise, E., Lyketsos, C. G., & Onyike, C. U. (2018). Aggression and Violence. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615371990.jl06
768. Woo, C. H., & Kim, S. (2014). Effectiveness of the Military Mental Health Promotion Program. Journal of Korean Academy of Nursing. https://doi.org/10.4040/jkan.2014.44.6.717
769. Wyatt, J. P., Illingworth, R. N., Graham, C. A., Hogg, K., Clancy, M., & Robertson, C. E. (2012). Environmental emergencies. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199589562.003.0006
770. Wyman, J. F. (1998). Quality of Life of Older Adults with Urinary Incontinence. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.1998.tb03816.x
771. Yanti, L., Andari, F. N., Novriadi, D., & Ferasinta, F. (2022). PENURUNAN INSOMNIA PADA LANSIA DENGAN TERAPI ZIKIR. Jurnal Pengabdian Masyarakat Bumi Raflesia. https://doi.org/10.36085/jpmbr.v5i3.3859
772. Yarlagadda, A. R., Brown, A. B., & Clayton, A. H. (2007). Onset of Obstructive Sleep Apnea After Initiation of Psychotropic Agents. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611h
773. Yetkın, S., & Çor, S. A. (2023). Psychological Inflexibility in Depression with Psychotic Features: A Case Report. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.2180
774. Young, P., Finn, B. C., Bruetman, J. E., Pellegrini, D. D. C. P., & Kremer, A. (2010). Enfoque del síndrome de astenia crónica. Medicina-buenos Aires.
775. Young, P., Finn, B. C., Bruetman, J. E., Pellegrini, D., & Kremer, A. (2010). [The chronic asthenia syndrome: a clinical approach].. PubMed.
776. Yung, A. R. (2011). Risk, Disorder and Diagnosis. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.3109/00048674.2011.614926
777. Yutzy, S. H. (2015). Somatic Symptom and Related Disorders: Somatic Symptom Disorder, Illness Anxiety Disorder, and Conversion Disorder. Psychiatry. https://doi.org/10.1002/9781118753378.ch62
778. Zamanian, S., & Rezaei, O. (2015). Comparison of Language Disorders in Psychotic Disorder (Schizophrenia, Bipolar Disorder, Drug-Induced Psychosis). Journal of Psychology Research.
779. Zamorski, M. A., & Ward, R. (2000). Social Anxiety Disorder: Common, Disabling, and Treatable. The Journal of the American Board of Family Medicine. https://doi.org/10.3122/15572625-13-4-251
780. Zauner, J. (1978). [Psychosomatic aspects of adolescence].. PubMed.
781. Zou, H., Zhou, H., Yan, R., Yao, Z., & Lu, Q. (2022). Chronotype, circadian rhythm, and psychiatric disorders: Recent evidence and potential mechanisms. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2022.811771
782. Zutshi, A., Math, S. B., & Reddy, Y. C. J. (2007). Escitalopram in Obsessive-Compulsive Disorder. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611c
783. Öngür, D., Beneš, F. M., Freudenreich, O., Keshava, M., & McCarley, R. W. (2021). Schizophrenia Spectrum and Other Psychotic Disorders. Cambridge University Press eBooks. https://doi.org/10.1017/9780511846403.005
784. Ďurdík, P., Olek, F., ov, U. J., an, T. T., & Bánovčin, P. (2020). Young and exhausted. Authorea (Authorea). https://doi.org/10.22541/au.159294140.04360533